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ABSTRACT
Two-hundred and thirty crude organic extracts from 118 plant species distributed 
among ten families of higher plants have been evaluated for antimycobacterial activity 
against Mycobacterium tuberculosis (H37R.V) and M. avium using the BACTEC 460 
radiorespirometric assay. At 100 pg/ml, twenty-four and ten of the extracts caused more 
than 95% inhibition of growth of M. tuberculosis and M. avium, respectively.
Bioactive chromatographic fractions of Borrichia frutescens (Asteraceae) 
provided two new triterpenes and one known cycloartenol. In radiorespirometric 
bioassays against M. tuberculosis, the new (24/?}-24,25-epoxycycloartan-3-one and the 
known (24j'?)-24,25-epoxycycloartan-3(3-ol exhibited minimum inhibitory concentrations 
(MICs) of 8 gg/ml. In contrast, the new (23/?)-3-oxolanosta-8,24-dien-23-ol showed no 
significant inhibition at 128 pg/ml.
In an attempt to study the structural dependence of antimycobacterial activity of 
the highly active guaianolide dehydrocostus lactone (MICs of 2 and 16 pg/ml against 
Mycobacterium tuberculosis and M. avium, respectively) and its derivatives, and to 
determine configurational and possible conformational effects upon activity, m- 
chloroperoxybenzoic acid oxidations of dehydrocostus lactone were performed. Three 
new monoepoxides, one previously synthesized diepoxide, and two new diepoxides were 
obtained, all of which showed strongly reduced antimycobacterial activity.
Antimycobacterial root extracts of Inula helenium and Rudbeckia subtomentosa 
were chemically investigated. Chromatographic fractions of active root extracts of /. 
helenium provided the known eudesmanolides alantolactone, isoalantolactone, and 1 lotH,
13-dihydroisoaIantolactone. Active fractions from root extracts o f R. subtomentosa gave
x
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the known alloalantolactone and 3-oxoalloalantolactone. All natural and semisynthetic 
eudesmanolides were tested for biological activity against XI. tuberculosis and 
demonstrated MICs ranging from 8 pg/ml for 5,6a-epoxyalantolactone to >128 pg/ml for 
11,13-dihydroisoalantolactone and 11,13-dihydroxyalantolactone.
Methanol extracts of fruits of Melia volkensii were chemically investigated and 
shown to contain two new triterpenes and the known triterpenoid kulonate. The 
structures of the new 12[}-hydroxykulactone and 6|3-hydroxykulactone were elucidated 
by ID and 2D NMR experiments and FABMS studies. All three triterpenes exhibited 
significant activity against M  tuberculosis with MICs ranging from 4 pg/ml to 16 pg/ml.
xi
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1.1 Epidemiology of Tuberculosis
According to the World Health Organization (WHO), the global prevalence of 
tuberculosis (TB) was estimated to be 1.7 billion persons, or approximately one-third of 
the world’s population (Kochi, 1991). Active disease develops in 8 to 10 million people 
per year, and TB is responsible for 3 million deaths per year, making it the leading 
infectious cause of death in the world, far surpassing measles (2 million deaths per year) 
and malaria (1 million) (Raviglione et al., 1995). Table 1.1 shows the worldwide 
distribution of TB divided amongst seven regions (Snider et al., 1994).
Table 1.1 Estimated global TB incidence and mortality in 1992
Area
Incidence Mortality
No. of cases Rate* No. of cases Rate0
Southeast Asia 3,263,000 240 1,142,000 84
Western Pacific* 1,921,000 136 672,000 48
Africa 1,182,000 214 468,000 85
Eastern Mediterranean 683,000 166 266,000 65
Americas0 584,000 128 117,000 26
Eastern Europe 197,000 47 29,000 7
Industrialized countries'* 199,000 22 14,000 2
All regions 8,029,000 146 2,708,000 49
° Per 100,000 population.
b All countries of the region except Australia, Japan, and New Zealand.
0 All countries o f the region except Canada and the United States. 
d Western Europe plus Australia, Canada, Japan, New Zealand, and the United States.
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Such dramatically high morbidity and mortality rates are in contrast to the 
experiences in the United States, even at the height of the problem. Beginning in the 
1920’s, annual rates of TB in the United States declined. In 1953, when official annual 
reporting began, there were 84,304 reported cases of tuberculosis; by 1984, reported 
cases had dropped to 22,255, a decrease of about 5% per year. However, in 1984 the 
trend reversed, and by 1988 the annual rate of TB in the United States began to rise. In 
1992, 26,673 cases, or about 10/100,000 persons, were reported (Sepkowitz et al., 1995).
1.2 Current Treatment Methodology
The current regimen for the treatment o f pulmonary TB evolved over many years 
and is based on dozens of clinical trials involving thousands of patients worldwide 
(Grosset et al., 1980). In 1990, the U. S. Public Health Service evaluated short course 
chemotherapy (6 versus 9 month) for pulmonary TB (Inderlied et al., 1996). On the basis 
of this study, a 6-month course o f isoniazid (1.1), rifampin (1.2), and pyrazinamide (1.3) 
for 2 months followed by isoniazid (1.1) and rifampin (1.2) for an additional 4 months 
was recommended for uncomplicated susceptible TB (Inderlied et al., 1996).
More recent problems in the treatment o f pulmonary TB are exacerbated by the 
AIDS pandemic and also by resistance to existing anti-TB drugs such as isoniazid, 
rifampin and streptomycin (Cohn et al., 1997). In general there are currently two key 
drugs in the treatment of TB: isoniazid and rifampin. Susceptibility to both allows 6 - to 
9-month regimens; susceptibility to rifampin but not isoniazid allows 9- to 12- month 
regimens; and susceptibility to isoniazid but not rifampin allows 12- to 18-month 
regimens. However, when the isolate is resistant to both isoniazid and rifampin, the 
outcome is uncertain (Sepkowitz et al., 1995).
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Since the introduction of rifampin in 1966, there have been no new drugs for the 
treatment of TB. The combined effects of the current pandemic AIDS and multi-drug 
resistant TB strains have created a need for the development and implementation of new 
TB drugs.
13  Review of Antituberculosis Terpenoids
Presented below is a review of terpenoids and other selected structural types of 
natural products that have been tested for biological activity against Mycobacterium 
tuberculosis, the gram-positive bacterium species primarily responsible for the disease 
TB. Over 75 % of the compounds discussed below have been evaluated for biological 
activity by our research group, the remaining compounds being tested by various other 
research groups. Their structural types have been divided into six categories; first and 
second line drugs (Figure 1.1), monoterpenes (Figure 1.2), sesquiterpenes (Figures 1.3 
and 1.4), diterpenes (Figure 1.5), triterpenes (Figures 1.6), and phytol derivatives and 
analogs (Figure 1.7). The biological activities o f each of the 145 compounds, which have 
been tested against M. tuberculosis, are presented in Table 1.2. Minimum inhibitory 
concentrations ranged from 2 pg/ml to >128 pg/ml.
13.1 Monoterpenes
The relatively inactive monoterpenes demonstrated MICs ranging from 50 pg/ml 
to 128 pg/ml. The lack of an adequate pool of monoterpenes tested against M 
tuberculosis makes it unreliable to speculate on conformational requirements for 
biological activity.
13.2 Sesquiterpenes
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Over 70 sesquiterpene lactones (SL) have been tested resulting in MICs ranging 
from 2 pg/ml to >128 pg/ml. In the discussion below, the SL were divided into two 
categories; the germacrolide-type SL represented by costunolide, parthenolide, and 
derivatives (Figure 1.3), and other SL shown in Figure 1.4.
Costunolide (1.14), the most lipophilic lactone among this category of 
sesquiterpenes, gave an MIC of 32 pg/ml. Its 4,5-epoxide derivative, parthenolide (1.16), 
was the most active germacrolide against M. tuberculosis with an MIC of 16 pg/ml. The 
1( lOVepoxycostunolide (1.18) was less active than 1.14 and 1.16 with an MIC of 64 
pg/ml. With the exception of 1,10-epoxyparthenolide (1.20), the sesquiterpene lactones 
in this series bearing a a-methylene-y-lactone moiety (1.14, 1.16, 1.18, 1.22, 1.24, and 
1.29) are active against M. tuberculosis with MICs at concentrations of 64 gg'ml or 
below. In contrast, their lipH , 13-dihydroderivatives (1.15, 1.17, 1.19, 1.23, and 1.25) 
as well as the sesquiterpenes obtained by reductive opening of the lactone ring (1.26, 
1.27, and 1.28) (Lu et al., 1996) showed no activity against M. tuberculosis at 
concentrations below 128 pg/ml, suggesting that the presence of the alkylating exocyclic 
a-methylene-y-lactone moiety is essential for activity.
Examination of the biological data for the additional sesquiterpenes (Figure 1.4), 
indicated that only 10 compounds out of the 61 in this category possessed MICs o f 32 
pg/ml or lower. The active compounds include damsin (1.39), dehydrocostuslactone 
(1.45), aromaticin (1.51), l,2-dehydro-3-epi-isotelekin (1.74), encelin (1.76), 4,5-epoxy- 
6-epidesacetyl-laurenobiolide (1.77), 6-epi-desacetyl laurenobiolide (1.78), curcuphenol 
(1.89), nerolidol (1.90), and famesol (1.91). The most active of these compounds is 
dehydrocostuslactone (1.45) with an MIC of 2 pg/ml.
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1 3 3  Diterpenes
Thirty-seven diterpenes have been tested against M. tuberculosis and seven of 
them possessed MIC less than 8 pg/ml (Figure 1.5). The seven active compounds, 
multicaulin (1.123), 12-demethylmulticauline (1.124), multiorthoquinone (1.125), 12- 
demethylmultiortho quinone (1.126), 12-methyl-5-dehydrohorminone (1.127), 12- 
methyl-5-dehydroacetylhorminone (1.128), and salvipimarone (1.129) were all isolated 
from Salvia multicaulis (Ulubelen et al., 1997). The most active o f these compounds was 
12-demethylmulticauline (1.124) which demonstrated a remarkable MIC of 0.46 pg/ml.
1.3.4 Triterpenes
Ten triterpenes have been tested against M. tuberculosis with only two 
demonstrating biological activities at 32 pg/ml (Table 1.2). One of these, fusidic acid 
(1.134), was isolated from a fermentation broth of Fusidium coccineumhas in 1962 
(Godtffedsen et al., 1962) and has been thoroughly investigated for clinical treatment 
against both M  leprae and M. tuberculosis (Hoffner et al., 1990 and references therein). 
The other active triterpene is cholesterol (1.136), which has an MIC of 32 pg/ml.
13.5 Phytol, derivatives, and analogs
The last set of compounds tested for biological activities against M. tuberculosis 
are the phytol, its derivatives, and structural analogs (Table 1.2) (Figure 1.7). Thirteen 
compounds were tested and all but three compounds demonstrated MICs at or below 32 
pg/ml. Three compounds, (£>phytol (1.140), (Z)-phyto! (1.145), and (3R£, 1R, 11R)- 
phytanol (1.146), demonstrated MICs of 2 pg/ml (Rajab et al., 1998). (£>phytyl acetate 
(1.141) and (£>phytol methyl ether (1.142) however, showed MICs of 16 pg/ml 
implying that a free hydroxyl group, as present in 1.140, is required for significant
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
activity. Additionally, the equipotency of (£>phytol (1.140), (Z)-phytol (1.145), and 
(3RJ>, 1R, 1 l/?)-phytanol (1.146) suggests that the 2,3-double bond may not be essential 
for bioactivity.







First and Second Line 
Drugs
isoniazid (1.1) 0.05 Heifets etal., 1991
rifampin (1.2 ) 0.25 Heifets et al., 1991
streptomycin (1.3) 2.0 Heifetsetal., 1991
ethambutol (1.4) 3.8 Heifets et al., 1991
pyrazinamide (1.5) 100 Heifetsetal., 1991
thiacetazone (1.6) 1.5 Heifetsetal., 1991
ethionamide (1.7) 1.25 Heifetsetal., 1991
ciprofloxacin (1.8) 1.0 Heifetsetal., 1991
Monoterpenes
dolabrin (1.9) 50 Ito et al., 1959
hinokitiol (1.10) 50 Ito etal., 1959




geraniol (1.13) Sigma 64
unpublished data 
Rajab et al., in press
Sesquiterpenes
costunolide (1.14) Saussurea lappa 32 Lu et al., 1996
1 ipH-dihydrocostunoIide synth. der. 128 Joshi etal., 1966
(1.15) 
parthenolide (1.16) Magnolia 16 Lu et al., 1996
1 ipH-dihydroparthenolide
grandiflora




synth. der. 64 Lu, et al., 1996
(1.18)
1, 10-epoxy dihydro synth. der. 128
costunolide (1.19)
(table continued)
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Compound Class i Source ! MIC i Reference
Name 1 i
1, 10-epoxvparthenolide ! synth. der. ! 128 ; Fischer et al., 1990
(1.2 0 ) j *
1, 10-epoxydihydro synth. der.1 | 128 1 Pentes, 1991parthenolide (1.2 1 ) Ii
santamarine (1.2 2 ) Ambrosia
confertiflora
64 ' Yoshioka et al, 1970
1
1 ipH, 13-dihvdro Sonchus hierrensis >128| j Bermejo Barrera et al.,
santamarine (1.23) i ; 1968
reynosin (1.24) Ambrosia
confertiflora
64 | Yoshioka et al, 1970
i
11 pH, 13-dihydroreynosin synth. der. ! >128 Lu et al., 1996
(1.25)
reynosin triol derivative >128 Luetal., 1996
(1.26)
11,13-dihydro triol of >128 Lu et al., 1996
reynosin (1.27)
santamarine triol derivative >128 Lu etal.. 1996
(1.28)
micheliolide (1.29) 50
costunolide diepoxide synth. der. 128
(1.30)
11 P-hydroxydihydro synth. der. 128 Pentes, 1991
parthenolide (131)
14-hydroxydihydro synth. der. 128 Pentes, 1991
parthenolide (1.32)
glaucolide A (133) Vemonia glauca 128 Padolina et al., 1974
melfiisin (134) Melampodium
diffusum
128 Quijano et al., 1981
montafrusin A (1.35) Montanoa
frutescens
>128 Quijano et al., 1979a
glaucolide D (136) Vemonia uniflora >128 Betkouski et al., 1975
11 P-hydroxydihydro synth. der. 128
costunolide (1.37)
pumilin (138) Berlandiera texana 128 Korpetal., 1982
damsin (139) Ambrosia maritima 32 Abu-Shady et al., 1953




128 Fischer et al., 1967




64 Herz et al., 1962b
tenulin (1.44) Helenium amarum 128 Herz et al., 1962a
(table continued)














| >128 j  Fronczek et al., 1984
i
(1-46)
zaluzaninC (1.47) j  Zaluzania triloba >128 |  Yabutaetal.. 1978




Joseph-Nathan et al., 
j  1966
peruvin acetate (1.49) j  synth. der. |  >128 l  Joseph-Nathan et al., 
|  1966









Ambrosia trifida ! >ioo 1 Luetal., 1993b
1 a -(2 -methylbutyroyloxy) 
carotol (1.53)
Ambrosia trifida ! >50
1
1
| Lu et al., 1993b




j Fischer et al., 1976
|




1 Fischer et al., 1975





j Fischer et al., 1976
1
1
calein C (1.58) Calea zacatechichi >128 Quijano et al., 1979b
neurolenin B (1.59) Neurolaena lobata >128 Manchand et al., 1978
zoapatanolide A (1.60) Montanoa
lomentosa
>128 Quijano etal., 1982
melcanthin A (1.61) Melampodium
leucanthum
128 Fischer et al., 1978b
melcanthin B (1.62) Melampodium
leucanthum
128 Fischer et al., 1978b
melampodin B hexanoate 
(1.63)
synth. der. 128 Walachv-Klimash,
1980
melampodin B palmitate 
(1.64)
synth. der. 128 Walachy-Klimash,
1980
melampodin B isobutyrate 
(1.65)
synth. der. 128 Walachy-Klimash,
1980
cinerenin hexanoate (1.66) synth. der. 128 Walachy-Klimash,
1980
cinerenin palmitate (1.67) synth. der. 128 Walachy-Klimash,
1980
cinerenin isobutyrate (1.68) synth. der. 128 Walachy-Klimash,
1980
cinerenin (1.69) synth. der. 128 Walachy-Klimash,
(table continued)










cinerenin acetate (1.70) ' synth. der. i 128
1980
' Walachy-Klimash.







synth. der. | >128
; 1980





liscunditrin (1.73) Liatris ohlingerae j >128 j Lu et al., 1994
1,2-dehydro-3-epi- Leo i 32 1i
isotelekin (1.74) | j i
i valin (1.75) Iva imbricata I 64 j Herzetal., 1964
encelin (1.76) Encelia farinosa 1 16 1 Geissman et al., 196!I 7
4,5-epoxy-6-epidesacetyl- 16
laurenobiolide (1.77) 




Artemisia ramosa >128 Gonzalez Gonzalez e
a-cyclocostunolide (1.80) synth. der. 64
al., 1975
!
(3-cyclocostunolide (1.81) synth. der. 64













fusarenone X (1.88) Fusariian nivale Ib Ueno et al., 1971
curcuphenol (1.89) Euthamia 16
nerolidol (1.90)
leptocephela





Rajab et al., 1998
Diterpenes
(+) 3P-hydroxymanool Solidago rugosa >100 Lu et al., 1995
(1.92)
(+)-3 P-acetoxymanool Solidago rugosa 128 Lu et al., 1995
(1.93)
(table continued)
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Compound Class Source ! MIC j Reference
Name i (ug/ml)* j
(+)-3p, I3-diacetoxymanool Solidago rugosa ! >128 1 Lu et al., 1995
(1.94) ! i
i
abietic acid (1.95) Solidago rugosa ! >100, Lu et al., 1995
kolavenic acid (1.96) Solidago canadensis >100 Lu et al., 1993a
kolavenol (1.97) Solidago canadensis >100 Luetal., 1993a
6 p-angeloyloxy kolavenic Solidago canadensis >100 Luetal., 1993a
acid (1.98)
6 P-tigloyloxy kolavenic Solidago canadensis >100 Lu et al., 1993a
acid (1.99)
solidago lactone (1.100 ) Solidago canadensis >100 Lu et al., 1993a
15,17-lactone grindelic S. pauciflosculosa >100 Menelaou et al., 1993
acid (1.101)
grindelic acid (1.102) >100 Menelaou et al., 1993
17-hydroxy grindelic acid S. pauciflosculosa >100 Menelaou et al., 1993
(1.103)
17-acetoxy grindelic acid S. pauciflosculosa >100 Menelaou et al., 1993
(1.104)
17-hydroxy grindelic acid S. pauciflosculosa >100 Menelaou etal., 1993
der. methoxy ester
(1.105)
grindelic acid der. diacid S. pauciflosculosa >100 Menelaou et al., 1993
(1.106)
hardwickiic acid (1.107) Solidago rugosa >128 Lu et al., 1995
13£'-7a-acetoxy kolavenic Solidago canadensis >100 Lu et al., 1993a
acid (1.108)
13Z-7a-acetoxy kolavenic Solidago canadensis >100 Lu et al., 1993a
acid (1.109)
cryptanol (1.110) Salvia pisidica Ic Topcu etal., 1987
horminone (1.111) Salvia pisidica Ic Topcu etal., 1987
7a-acetylhorminone Salvia pisidica Ic Topcu etal., 1987
(1.112)
femiginol (1.113) Salvia pisidica f Topcu etal., 1987
pisiferal (1.114) Salvia pisidica r Topcu etal., 1987
danshenxinkun D (1.115) Salvia miltiorrhiza Ac Luo et al., 1985
hypargenin A (1.116) Salvia hypargeia Ulubelen et al., 1988
hypargenin B (1.117) Salvia hypargeia Ib Ulubelen et al., 1988
hypargenin C (1.118) Salvia hypargeia
Jb
Ulubelen et al., 1988
hypargenin D (1.119) Salvia hypargeia T Ulubelen et al., 1988
hypargenin E (1.120) Salvia hypargeia rb Ulubelen et al., 1988
hypargenin F (1.121) Salvia hypargeia yb Ulubelen et al., 1988
sandaracopimara-8( 14)-15- Tetradenia riparia 25-100° Puyvelde et al., 1994
diene-7-a,l8-diol (1.122)
multicaulin (1.123) Salvia multicaulis 5.6 Ulubelen et al., 1997
12 -demethylmulticauline Salvia multicaulis 0.46 Ulubelen et al., 1997
(table continued)

















' Ulubelen et al., 1997













Ulubelen et al., 1997
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baccharis oxide (1.132) Baccharis
hahmifolia
>128
betulin (1.133) Betula sp. 128
fusidic acid (1.134) .32 Hoffner et al., 1990
(3-sitosterol (1.135) Aldrich >128
cholesterol (1.136) Aldrich 32
harrisonin (1.137) H. abyssinica >128 Rajab et al., 1997
12(3-acetoxyharrisonin H. abyssinica >128 Rajabetal., 1997
(1.138)
vitamin D3 (1.139) Aldrich 128
Phytol, derivatives, and 
analogs
(£>phytol (1.140) Lucas volkensii 2 Rajab et al., 1998
(£>phytyl acetate (1.141) synth. der. 16 Rajabetal., 1998
(£>phytol methvl ether 
(1.142)
synth. der. 16 Rajab et al., 
unpublished data




synth. der. 64 Rajab et al., 
unpublished data
(Z>phytol (1.145) Aldrich 2 Rajabetal., 1998
(3R£, 7R, 1 l/?>phytanol synth. der. 2 Rajab et al., 1998
(1.146)
(£>phytol epoxide (1.147) synth. der. 8 Rajab et al., 1998
(3RJS, 7R, 1 lR)-phytanic 
acid (1.148)
synth. der. >128 Rajab etal., 1998
(table continued)








2-phytolphenol (1.149) synth. der. t  32
1
! Rajab et al.,
! unpublished data
phytantriol (1.150) Aldrich i11
j Rajab et al., 
unpublished data
diphytylsulfide (1.151) synth. der. 1 >128i
j
! Rajab et al.,
I unpublished data





a Biological activity determined using BACTEC radiorespirometric bioassay except 
where noted otherwise. I=Inactive; A=Active. 
b Biological activity determined using agar plate. 
c Biological activity determined by unreported method.
1.4 Conclusions
It has been demonstrated above that natural products are an excellent source for 
the identification of new structural types of antimycobacterial compounds. These 
investigations have led to the isolation and structural elucidation o f over 27 compounds 
with MICs at or below 32 pg/ml. Eleven compounds, dehydrocostuslactone (1.45), 
multicaulin (1.123), 12-demethylmulticauline (1.124), multiorthoquinone (1.125), 12- 
demethylmultiortho quinone (1.126), 12-methyl-5-dehydrohorminone (1.127), 12- 
methyI-5-dehydroacetylhorminone (1.128), and salvipimarone (1.129) (£>phytol (1.140), 
(Z)-phytol (1.145), and (3RJS, 7R, 1 l/?)-phytanol (1.146), showed remarkable MICs of 2 
pg/ml or lower. These data indicate that the sesquiterpene, diterpene, and phytol classes 
of molecules may be good sources of chemicals or synthetic models for future 
investigations. However, this observation can only be substantiated by additional testing 
of other types of terpenoids. All data discussing preliminary structure activity 
relationships will require additional biological testing of structurally similar compounds.
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Figure 1.1. First and second line antimycobacterial drugs
(figure continued)























Figure 1.2. Monoterpenes tested against M tuberculosis






1.19=11PH, 13-dihydro 1.21=1 lpH, 13-dihydro
OH OH
1.22 1.24






Figure 1.3. Costunolide, parthenolide, and derivatives tested against M. tuberculosis


















Figure 1.4. Additional sesquiterpenes tested against M tuberculosis
(figure continued)
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1.63 R I=Ac, R2=hexanoate
1.64 R 1=Ac, R2=palmitate
1.65 R l=Ac, R2=isobutyrate
1.66 R I=Et, R2=hexanoate
1.67 R1=Et, R2=palmitate
1.68 R 1=Et, R2=isobutyrate
1.69 R I=Et, R2=OH
1.70 R1=Et, R2=OAc
1.71 R l=Et, R2=cinnamate
1.72 R 1=isobutyl, R2=acetate
(figure continued)











































1.94 R l=Ac, R2=Ac
1.96 R=H, R1=COOH
1.97 R=H, Rl=CH2OH
1.98 R=OAng, R 'C O O H
1.99 R=OTig, R‘=COOH







1.102 R=COOH, R 1=H









Figure 1.5. Diterpenes tested against M  tuberculosis
(figure continued)


















1.116 r ‘=r 4=o , r 2=r 3=h , R5=P-OH








































Figure 1.6. Triterpenes tested against M. tuberculosis























Figure 1.7. Phytol, derivatives, and structural analogs tested against M. tuberculosis
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ANTIMYCOBACTERIAL CRUDE PLANT EXTRACTS 
FROM SOUTH, CENTRAL, AND NORTH AMERICA*
* Reprinted with permission from Phytomedicine, 5, 139-147 (1998), copyright 1998.
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2.1 Introduction
It is estimated that annually 8 to 10 million individuals fall victim to tuberculosis 
and about 3 million die (Raviglione, et al., 1995). The problem is exacerbated by the 
AIDS pandemic and also by resistance to existing anti-TB drugs such as isoniazid, 
rifampin and streptomycin (Cohn et al., 1997). Since the introduction of rifampin in 
1966, no new drugs have been made available for the treatment of this disease. 
Mycobacterium avium is a more recently recognized opportunistic pathogen, causing 
disease almost exclusively in immunosuppressed patients. Although considerably less 
virulent than M  tuberculosis, it has a greater innate resistance to most available 
antimicrobics including the anti-tuberculosis drugs.
Although there are many reports of primary screenings of crude plant extracts with 
the intent of identifying new TB-active compounds, relatively few have employed 
authentic M. tuberculosis and used quantitative dilution assays (as opposed to diffusion 
assays which are affected by other factors such as molecular weight and hydrophobicity).
In an effort to identify sources for bioassay-directed isolation of novel compounds 
active against M. tuberculosis and M avium, extracts of 118 plant species from South, 
Central and North America were screened using a procedure which allows activity to be 
quantitated in such a way that the extracts can be prioritized for further study.
2.2 Experimental
Plant material and extract preparation. Two-hundred and thirty different 
crude extracts were prepared from 118 different plant species collected in various 
locations in North, Central, and South America. All voucher specimens were deposited 
at the Louisiana State University Herbarium in Baton Rouge, Louisiana. Nomenclature
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for the North American taxa follows Kartesz (Kartesz, 1994). Approximately 500 g of 
plant material of each species were allowed to air dry and subsequently ground in a 
Thomas Wiley Mill (model 4). Plant material was soaked in the appropriate solvent(s) for 
24-48 hours. The solvent was removed using a rotary evaporator followed by high 
vacuum for 18 hours.
Anti-mycobacterial testing. All extracts were solubilized at 80 mg/ml in 
dimethylsulfoxide (DMSO), sterilized by passage through a 0.22 pm PFTE filter (Millex- 
FG, Millipore, Bedford, MA) and stored at -80°C until used. A 1:10 dilution was made 
in DMSO and 50 pi of both stocks and dilutions added to 4 ml 7H12 medium (BACTEC 
12B; Becton Dickinson Diagnostic Instrument Systems, Sparks, MD) to achieve the 
desired final concentrations of 1000 and 100 pg/ml. Controls received 50 pi DMSO. 
Positive drug controls for M. tuberculosis and M. avium received, respectively, either 
fixed concentrations of 2 pg/ml rifampin (Sigma Chemical Co., St. Louis, MO) and 32 
pg/ml clarithromycin (Abbott Labs, North Chicago, EL) or a range of concentrations to 
determine the minimum inhibitory concentrations (MIC).
Anti-mycobacterial bioassays were performed using the BACTEC 460 system 
(Collins and Franzblau, 1997) as modified below to determine percent inhibitions with 
plant extracts. M  tuberculosis H37Rv ATCC 27294 (American Type Culture Collection, 
Rockville, MD) was cultured in BACTEC 12B broth until the daily growth index (GI) 
reached 400-999. One-tenth ml of this culture was used to inoculate 4 ml fresh BACTEC 
12B media containing the plant extracts.
M. avium ATCC 25291 was cultured in BACTEC 12B broth until the daily GI 
reached 999. Cultures were then diluted 1:25 in BACTEC 12B broth and frozen at -80°C
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until needed. One-tenth ml of the thawed culture was used to inoculate 4 ml fresh 
BACTEC 12B media containing the plant extracts.
For both M. tuberculosis and M  avium, additional control vials were included 
which received a further l:lOO-diluted inoculum for use in calculating the MIC of 
rifampin and clarithromycin, respectively, by established procedures (Inderlied and 
Salfinger, 1995; Inderlied and Nash, 1996).
Cultures were incubated at 37°C and the GI determined daily (starting on the third 
day of incubation) until (solvent) control cultures achieved a GI of 999. Assays were 
completed in 10 days for M. tuberculosis and 5 days for M. avium. Percent inhibition 
was defined as 1-(GI of test sample/GI of control) x 100.
2.3 Results
The results from screening organic extracts of 118 different plant species against 
M. tuberculosis and M. avium at 1000 pg/ml and 100 pg/ml are shown in Table 2.1. 
Some extracts were only screened at 1000 pg/ml and due to lack of activity or sample 
were not tested at 100 pg/ml. Other extracts were only tested at the lower concentration 
due to limited sample availability.
Extracts, which demonstrated high activity (>90% inhibition) against both 
mycobacteria at 100 pg/ml included: Chrysacthimia mexicana, Erigeron annua, E. 
strigosus, Euthamia leptocephala, Rudbeckia subtomentosa, Solidago petiolaris, 
Magnolia acuminata and M. grandiflora.
Extracts which demonstrated high activity against M. tuberculosis and moderate 
or weak activity against M. avium included: Aster praeltus, Borrichia frutescens, Calea
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Jivaricata, Celtis laevigata, Echinacea artrorubens, Gaillardia aestivalis, Heterotheca 
subaxillaris, Liatris ohlingerei, Solidago arguta and Polygonella fimbriata.
Extracts with high activity against M. tuberculosis and little to no activity against 
M. avium at 100 pig/ml included: Ambrosia artemisiifolia, and Rudbeckia lacmiata. No 
extracts demonstrated significantly greater activity against M. avium compared to M  
tuberculosis.
Roots had greater activity than aerial parts (flowers, leaves or stems) in 
dichloromethane extracts of Ambrosia artemisiifolia, Aster praeltus, Echinacea 
artrorubens, Erigeron philadelphicus, E. strigosus, Euthamia leptocephala, Gaillardia 
aestivalis, Liatris acidota, Rudbeckia laciniata, R. subtomentosa, and Solidago 
semperivens as well as in methanol extracts of Solidago rugosa, hexane extracts o f 
Echinacea artrorubens and acetone extracts of Camptotheca acuminata.
In plants which demonstrated significant activity against one or more 
mycobacteria and for which the same plant part was extracted with more than one 
solvent, activities of different solvent extracts could be compared. Dichloromethane 
extracts had higher activities than methanol extracts in 8 species. Hexane extracts were 
more active than dichloromethane in 3 species and hexane extracts were more active than 
methanol extracts in 2 species. In no cases were the reverse relative activities observed.
2.4 Discussion
To our knowledge this is the first large-scale examination of the anti- 
mvcobacterial activity of crude plant extracts using the BACTEC 460 radiorespirometric 
assay, the clinical TB drug susceptibility method of choice for most o f the past 10 years 
(Inderlied and Nash, 1996; Inderlied and Salfinger, 1995). Instead of performing a
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Table 2.1. Antimycobacterial Activity of Various Crude Plant Extracts
Family Plant Location Exa Percent Inhibition
Part
Species M - M .
tuberculosis avium
1000 100 1000 100 
pg/ml tig/ml pg/ml ng/ml
Apocynaceae
Vinca rosea L. aerial Louisiana D 100 40 0 0
aerial Louisiana M 100 - 0 -
Asteraceae
Ageratina altissima (L.) aerial Louisiana D 100 3 - 0
King & H. E. Robins
Alloispermum aerial Venezuala D 100 81 100 79
caracasanum (H. B. K.) 
H. Robinson
Ambrosia artemisiifolia L. aerial Louisiana H 98 79 91 0
aerial Louisiana D 97 58 - 0
aerial Louisiana W 6 - - -
roots Louisiana D 99 94 - 0
Ambrosia confertiflora aerial Texas H 69 35 99 0
DC.
aerial Texas C 100 34 - 60
aerial Texas D -42 - 0 -
Ambrosia trifida L. aerial Louisiana M 3 - 0 -
Artemisia annua L. aerial Oregon D - 77 - 0
Artemisia douglasiana aerial Oregon D - 22 - 0
Bess.
Artemisia ludoviciana ssp. aerial Oregon D - 4 - 0
estesii Chambers
Artemisia ludoviciana var. aerial Oregon D - 29 - 0
vatiloba Nutt.
Aster adnatus Nutt. aerial Louisiana D 64 - - -
Aster praealtus Poir. aerial Louisiana D 35 - 0 -
flower Louisiana D 53 - 0 -
roots Louisiana D 97 93 94 43
(table continued)






Location Ex8 Percent Inhibition
M M  
tuberculosis avium 
1000 100 1000 100 
pg/ml pg/ml pg/ml pg/ml
Baccharis halimifolia L. roots Louisiana D 100 58 98 87
Balsamorhiza hookeri aerial Colorado D 98 30 61 0
Nutt.
Balsamorhiza sagittata aerial Wyoming D 81 - 0 -
(Pursh) Nutt.
Berlandiera lyatra Benth. aerial Texas D 31 - 48 -
Berlandiera pumila aerial Texas D 81 - 1 -
(Michx.) Nutt.
Berlandiera texana DC. aerial Texas D 46 - 48 -
Bigelowia nuttallii L. C. aerial Louisiana D 100 75 68 6
Anders
aerial Louisiana A 95 49 48 0
roots Louisiana D 99 50 0 0
Borrichia frutescens (L.) flower Louisiana H 78 - - 71
DC.
flower Louisiana D 99 100 99 52
leaves Louisiana D 100 90 100 72
roots Louisiana H 99 - - -
roots Louisiana D 94 - - -
roots Louisiana M 84 23 33 1
Calea berteriana DC. aerial Venezuela D 100 54 100 64
Calea cardonae Maguire aerial Venezuela D 100 89 100 97
& Wurdack
Calea divaricata Benth. aerial Venezuela D 100 98 100 85
Calea orizabaensis Klatt aerial Mexico D 99 26 99 0
var. websteri Wussow & 
Urbatsch
Calea prunifolia Kunth aerial Venezuela D 100 52 100 41












Location Exa Percent Inhibition
A/. A /.
tuberculosis avium
1000 100 1000 100
Ug/ml pg/ml pg/ml pg/ml
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1000 100 1000 100
pg/ml pg/ml pg/ml pg/ml
leaves Texas D -13 - - -
roots Texas H 100 - 100 -
roots Texas D 100 - 100 -
stems Texas D 100 94 100 36
Elephantopus sp. aerial Venezuala D 100 67 99 41
Elephantopus carolinianus roots Louisiana D 98 35 - 0
Raeusch.




aerial Texas D 96 68 _ 17
Gray ex Nutt.
flower Texas D 100 -3 - 0
flower Texas M 2 - - -
Ericameria arborescens aerial California C 97 61 58 24
(Gray) Greene
Ericameria cuneata (Gray) aerial California C 68 - - -
McClatchie
Ericameria ericoides aerial California D 72 - 51 -
(Less.) Jepson
Ericameria nana Nutt. aerial California D 5 - 0 -
Erigeron annuus (L.) Pers. roots Louisiana D 100 99 - 99
Erigeron philadelphicus L. aerial Louisiana D -38 - - -
aerial Louisiana W 26 - 0 -
roots Louisiana D 100 -18 - 0
Erigeron strigosus Muhl. aerial Louisiana D 100 56 - 55
ex Willd.
roots Louisiana D 100 100 - 100
Erigeron tenuis Torr. & aerial Louisiana D -46 - - -
Gray
Espeletia sp. aerial Merida, D 100 77 100 38
Venezuela
(table continue<











1000 100 1000 100
Espeletia schultzii Wedd. aerial Mugubaji,
Venezuela
D 100 23 0 0
Eupatorium altissimum L. aerial Louisiana D -47 - - -




D 100 83 - 73
Euthamia leptocephala aerial Louisiana D 100 22 - 19
(Torr. & Gray) Greene
flower Louisiana D 100 -11 - 0
leaves Louisiana D 99 -31 - 67
roots Louisiana D 100 73 100 94
stems Louisiana D 83 -17 0 0
Gaillardia aestivalis flower Louisiana D 97 40 8 0
(Walt.) H. Rock
leaves Louisiana D 98 52 78 0
roots Louisiana D 100 99 100 58
stems Louisiana D -37 - 0 -
Gaillardia pulchella Foug. leaves Louisiana D 100 65 0 0
Garberia heterophylla leaves Florida H 100 _2 50 0
(Bartr.) Merr. & F. 
Harper
Gundlachia corymbosa leaves Bahamas D 99 61 98 56
(Urban) Britt, ex 
Boldingh




buds Louisiana D 89 - 20 -
leaves Louisiana D 54 _ 0 _
Heterotheca camporum aerial Tennessee D -35 - - -
(Greene) Shinners
(table continued)






Location Exa Percent Inhibition
M. M. 
tuberculosis avium 
1000 100 1000 100 
pg/ml pg/rnl pg/ml pg/ml
Heterotheca subaxillaris roots Louisiana H 100 98 99 44
(Lam.) Britt. & Rusby
roots Louisiana D 100 71 55 0
Hymenoxys scaposa (DC.) aerial Texas H 70 - - -
K. F. Parker
aerial Texas D 100 59 - 0
aerial Texas M 100 15 100 0
Inula helenium L. roots Louisiana H 100 100 - -
roots Louisiana D 100 100 - -
roots Louisiana M 100 83 - -
Liatris acidota Engelm. & aerial Texas D 12 14 0 0
Gray
aerial Texas M 18 20 0 0
flower Texas D 73 13 0 0
flower Texas M 5 25 0 0
roots Texas D 100 87 99 61
roots Texas M 27 13 0 0
Liatris ohlingerae (Blake) aerial Florida D - 96 - 75
B. L. Robins
Melampodium cinereum aerial Texas D 100 25 35 0
DC.
Melampodium aerial Costa Rica D 100 - 0 -
costaricense Stuessy
Melampodium leucanthum aerial Texas D 81 - 88 -
Torr. & Gray
leaves Texas D 66 - 76 -
Melampodium longicome aerial Arizona D 53 - 0 -
Gray
roots Arizona M -11 - - -
Montanoa tomentosa aerial Mexico D 100 - • _
Cerv.
(table continued)
















Rudbeckia grandiflora (D. 











aerial Mexico M 99 - 59 -
aerial Louisiana D 100 82 100 43
aerial Arkansas D 99 41 0 0
aerial Arkansas M 23 9 0 0
aerial Texas D 84 5 0 0
aerial Texas M 43 11 0 0
aerial Mexico 1st
D
-47 - - -
aerial Mexico 2nd
D
-29 - - -
aerial Mexico E 99 18 - 0
aerial Tamaulipas 
, Mexico
D 100 94 99 52
flower Louisiana D -10 - - -
flower Louisiana EE -3 _ _ _
leaves Louisiana D -41 - - -
leaves Louisiana EE -35 - - -
roots Louisiana D 19 - - -
roots Louisiana EE -16 - - -
flower Louisiana D -29 - - -
leaves Louisiana D 93 _ _ _
roots Louisiana D 100 70 - 80
roots Louisiana M -1 - 0 -
stems Louisiana D -47 - - -
flower Mississippi D -47 - - -
roots Mississippi D 99 99 - 0
(table continued)











Smallanthus uvedaha (L.) 
Mackenzie ex Small
Solidago arguta Ait. 
Solidago canadensis L. 
Solidago nemoralis Ait.
Solidago odor a Ait.
Solidago petiolaris Ait.
Solidago rugosa P. Mill.




1000 100 1000 100 
_______________________ M-g/ml pg/ml ug/ml pg/ml
stems Mississippi D 79 - -
flower Arkansas H 100 - 97
flower Arkansas D 100 - 0 -
flower Arkansas M -15 - 0 -
roots Arkansas H 100 - 97 -
roots Arkansas M -47 - 0 -
stems Arkansas M -22 - 0 -
flower Louisiana D 95 30 - 22
leaves Louisiana D 96 43 0
roots Louisiana D 100 99 - 98
stems Louisiana D 70 - - -
aerial Ohio H 98 65 - 6
aerial Ohio D 95 34 _ 0
aerial Ohio M 21 - - -
aerial Louisiana D 64 - 0 _
aerial Louisiana M -27 - 0 -
roots Louisiana D 100 100 99 80
aerial Louisiana D -29 - - -
aerial Louisiana D 100 82 98 19
aerial Louisiana M 26 3 0 0
aerial Louisiana D 100 36 100 11
aerial Louisiana M 21 14 19 0
aerial Louisiana D 100 93 99 94
aerial Louisiana A 100 99 100 98
flower Louisiana D 100 35 - 0
roots Louisiana D 100 10 80 0
(table continued)











1000 100 1000 100
roots Louisiana M 86 25 0 0
stems Louisiana D 100 2 23 0
stems Louisiana M 22 16 0 0
Solidago sempervirens L. aerial Louisiana D 100 20 89 0
roots Louisiana D 100 63 100 59
Tetrachyron brandegei aerial Mexico D 100 65 99 59
(Greenman in 
Brandegee) Wussow & 
Urbatsch
Tetrachyron grayi (Klatt) aerial Mexico D 99 88 96 23
Wussow & Urbatsch
Tetrachyron manicata aerial Mexico D 82 - 42 -
(Schlechtendal) 
Bentham & Hooker ex 
Hemsley
Tetragonotheca repanda aerial Texas D 96 - - -
(Buckl.) Small
Trigonospermum annuum aerial Guatemala D 100 35 0 0
McVaugh & Laskowski
Verbesina virginica L. aerial Louisiana D 63 - 0 -
Viguiera cordifolia Gray aerial Costa Rica D -9 - - -
aerial Costa Rica M -36 - 0 -
Viguiera dentata (Cav.) leaves Mexico D 100 7 62 0
Spreng.
leaves Mexico M 100 17 - 0
stems Mexico D 99 - - -
Xanthium strumarium L. aerial Louisiana PE 70 - 0 -
aerial Louisiana D -12 - - -
aerial Louisiana M 12 - 0 -
Youngia japonica (L.) DC. aerial Louisiana D 100 62 0 0
Empetraceae
(table continued)
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1000 100 1000 100 
_______________________ Hg/ml M-g/ml p-g/ml ug.ml










98 - 99 “
aerial Florida M 38 - 55 -
Calamintha coccinea aerial Mississippi D 100 76 0 9
(Nutt, ex Hook.) Benth.
Conradina canescens Gray leaves Florida D 100 - 99 -
Lauraceae
Per sea humilis Nash leaves Florida D 99 - 97 -
stems Florida E 9 - - -
Magnoliaceae
Liriodendron tulipifera L. leaves Louisiana D 100 50 - 0
Magnolia acuminata (L.) 
L.
aerial Louisiana D 99 100 100 99
bark Louisiana D 100 100 100 100
Magnolia grandiflora L. flower
petals
Louisiana D 100 99 - 91
fruit Louisiana D 100 80 - 84
leaves Louisiana D 100 88 - 92
Magnolia macrophylla leaves Mississippi D 20 - - -
Michx.
Magnolia pyramidata leaves Mississippi D - 33 - 0
Bartr.
Magnolia virginiana L. aerial Mississippi D 100 - - -
flower Mississippi D 100 - - -
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1000 100 1000 100
pg/ml pg/ml pg/ml pg/ml
Camptotheca acuminata leaves Louisiana PE -35 20 0 0
Decne.
leaves Louisiana D -24 7 0 0
leaves Louisiana A 2 4 0 0
roots Louisiana A 72 2 0 0
Nyssa sylvatica Marsh. leaves Mississippi H 100 - 85 -
leaves Mississippi D 100 - -25 -
leaves Mississippi A -36 - 15 -
leaves Mississippi M -41 - -6 -
Polygonaceae
Polygonella fimbriata leaves Florida D -9 - - -
(Ell.) Horton
stems Florida D 100 100 100 0
Polygonella robusta aerial Florida H 10 1 26 0
(Small) Nesom & Bates
aerial Florida D 34 -6 18 0
aerial Florida M 6 -18 - 0
roots Florida H -5 -13 24 0
roots Florida D -9 -30 40 30
roots Florida M 16 -4 57 0
Selaginellaceae
Selaginella arenicola L. leaves Florida H 58 - - -
Underwood
leaves Florida D 10 - - -
Ulmaceae
Celtis laevigata Willd. berries Mississippi D 99 99 39
a Ex = Extraction Solvent, D = Dichloromethane, E = Ethanol, M = Methanol, C = Chloroform, W = 
Water, H = Hexane, A = Acetone, EE = Ethyl Ether, PE = Petroleum ether.
Plant material within the same species and plant part was extracted consecutively in the order indicated in 
the table using least polar to most polar solvents.
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classical determination of the MIC by testing at multiple concentrations, a ranking of 
activity (and examination of dose response) was performed by determining the percent 
inhibition effected by various extracts at only two concentrations; 1000 and 100 pg/ml. 
The quantitative nature of the BACTEC 460 system, yielding a “growth index” (or 
measure of l4CO: evolution from i4C-palmitic acid) lends itself well to this type of 
analysis. Nonetheless, the BACTEC is quite expensive, and requires the use of 
radioisotopes and is not considered a high-throughput format. The recently described 
rapid, inexpensive, microplate-based assays utilizing reporter genes such as firefly 
luciferase (Shawar et al., 1997), green fluorescent protein (Collins et al., submitted) or 
redox dyes such as Alamar Blue (Collins and Franzblau, 1997) should facilitate the 
future high-throughput screening of plant extracts for anti-mycobacterial activity.
A detailed literature search of the species (or genera) tested in this study revealed 
that several have ethnomedical documentation of use in tuberculosis or respiratory 
disorders in general (which may have included tuberculosis) and some of the collections 
were in fact based on ethnobotanical leads.
Cherokee, Mohicans, and Lriquois used decoctions and infusions of Inula 
helenium roots to treat respiratory disorders which could have been the manifestations of 
tuberculosis (Moerman, 1986). Both fresh leaf juice (Fitzpatrick, 1954) as well as 
ethanolic extracts (Grange and Davey, 1990) of I. helenium were shown to inhibit growth 
of M  tuberculosis H37Rv. In the present study, the crude organic extract of I. helenium 
was among the most active, effecting 100 percent inhibition against M tuberculosis at 
100 pg/ml. I. helenium contains the well known eudesmanolides, alantolactone and
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isoalantolactone (Milman, 1990) and the MIC of a mixture of these compounds was 
reported to be 31.2 pg/ml (Bichkanova et al., 1977).
A decoction of the roots of Elephantopus scaber was used by natives of the 
Lamjung district o f Nepal for treating hemoptysis, a symptom (but not exclusively) of 
tuberculosis (Manandhar, 1987). Both Artemisia abrotanum and A. vulgaris (Duke, 
1985) were used for treating tuberculosis among other ailments as were several species of 
Baccharis.
Fitzpatrick (1954) examined the fresh juices of many plant species for the 
presence of anti-TB activity, expressed as the lowest dilution of the plant juice which 
prevented visible growth of M. tuberculosis on solid medium. Active species from 
genera which were also assessed in the current study included Inula helenium (>1:80) and 
Nyssa sylvatica (>1:160, after tannin removal, 1:80). Inactive species (at 1:20 or 1:40) 
included Ageratina altissima, Magnolia macrophylla, and Magnolia virginiana.
The data obtained here provide a valuable, quantitative basis on which to 
prioritize plants for further study. A case in point is Borrichia frutescens which was 
recently shown to contain various cycloartane derivatives, one of which had an MIC of 8 
pg/ml against M. tuberculosis (Cantrell et al., 1996). Further investigation of other plants 
with high activity is currently in progress.
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3.1 Introduction
In our continued search for biologically active natural products from higher plants 
of the southeastern USA, we investigated the aerial parts of the sea daisy, Borrichia 
firutescens (L). DC. This monotypic genus of the family Asteraceae, tribe Heliantheae, is 
a widely distributed halophyte in the saline and brackish coastal marshes of Louisiana 
and other neighboring Gulf Coast states. A previous chemical study of B. frutescens 
from Veracruz, Mexico has afforded the triterpenes stigmastanol, stigmasterol, and 
oleanolic acid as well as the heliangolide-type sesquiterpene lactone zoapatanoiide A 
(Delgado et al., 1992; Quijano et al., 1982). We describe below the structures of two 
new triterpenes, one cycloartanone and one lanostadiene, from the flowers o f B. 
frutescens collected near Grand Isle, Louisiana.
3.2 Results and Discussion
Crude dichloromethane extracts of the flowers, leaves, and stems of B. frutescens 
were tested by a radiorespirometric method for activity against M. tuberculosis (H37Rv) 
(Heifets et al., 1991). The highest level of antimycobacterial activity was found in the 
flower extract, which was separated into eight fractions with increasing solvent polarity 
by a standard VLC procedure using silica gel (Table 3.1). Activities of the eight fractions 
against M  tuberculosis, which are also listed in Table 3.1, indicated that the nonpolar 
fractions 2-4 of the crude flower extract exhibited the highest inhibitory activity. At 33 
(ig/ml, all three fractions showed inhibitions of 95% or higher, while all other fractions 
gave values near 30% or below. Chemical investigation of fractions 2-4 led to the 
isolation of two new triterpenes (3.1 and 3.4) and one known triterpene (3.3a), the 
structures of which were elucidated as described below.
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Compound 3.1, C30H48O2, mp 119-122°, gave a strong IR absorption at 1708 
cm-1, suggesting the presence of ketone group(s). The 'H-NMR spectrum of 3.1 (Table 
3.2) exhibited seven methyl signals and two upfield, mutually coupled one-proton 
doublets at 8 0.57 and 0.78, which indicated the presence of a cyclopropane methylene 
group in the molecule. The above JH-NMR data together with a mass spectral peak at 
m z 440 lead us to suggest a cycloartanone-type triterpene skeleton. The absence of an IR 
OH absorption in 3.1 together with the NMR spectral comparison o f 3.1 with the known 
cycloartanone desoxypreffutecin B (3.2) (Jakupovic et al., 1987) strongly suggested that 
compound 3.1 differed from 3.2 only in the absence of a C-16 P-hydroxyl group in 3.1. 
This was supported by the lack of the downfield multiplet (H-16) in 3.1, which appeared 
at 8 4.44 in 3.2 (Jakupovic et al., 1991). Also, the methyl absorption at 8 1.19 in 3.2 (C- 
13 methyl) was shifted upfield in 3.1 (8 0.99), supporting the absence of the deshielding 
P-hydroxyl group at C-16 in 3.1.
The 13C-NMR spectrum of 3.1 (Table 3.3) and DEPT experiments confirmed the 
presence of seven methyls, a ketone (8  216.5), a cyclopropane methylene (8 29.5, t), and 
an epoxide group at C-24-25 (8 64.7 and 58.3). 13C-NMR assignments were based on 
DEPT experiments as well as spectral comparison with a previously reported structural 
analogue, which differed from 3.1 only in the position o f the epoxide function (C-23-C- 
24) in the cycloartenone side chain and the presence of a P-hydroxyl group at C-16 as in
3.2 (Herz et al., 1985). Differences observed included the absence o f the C-16 oxygen- 
bearing carbon signal in 3.1, and the presence of epoxide carbon absorptions in 
agreement with a C-24-C-25 epoxide group as shown in 3.1, exclusive of
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stereochemistry. The mass spectrum confirmed the molecular weight of 3.1 with a parent 
peak m z  440.7 and a strong peak at m z  313 corresponding to the fragment of the 
tetracyclic ring system by loss of the side-chain. Crystallization of 3.1 from hexane- 
EtOAc (19:1) provided crystals suitable for single-crystal X-ray diffraction analysis, 
which unambiguously established the molecular structure and relative stereochemistry of
3.1 as shown in Figure 3.1. Table 3.4 lists its crystallographic data and the coordinates 
are given in Table 3.5. Details of the X-ray data of 3.1 will be discussed at the end of 
this section. A negative CD Cotton effect near 295 nm was observed for 3.1 which 
confirmed the absolute stereochemistry as that shown in structural formula 3.5.
From a more polar VLC fraction (hexane-EtOAc, 9:1), a colorless crystalline 
compound (3.3a, mp 101-103 °C) was obtained, which differed from 3.1 only in the 
presence of a P-hydroxyl group at C-3 instead o f the ketone group in 3.1, as indicated by 
the lack of a carbonyl absorption and the presence of a hydroxyl IR band at 3387 cm*1. 
The empirical formula, C30H50O2, was initially derived from 'H- and 13C-NMR spectral 
data including DEPT experiments as well as mass spectral values. The mass spectrum 
gave a parent peak at m z  442, which indicated a molecular weight two mass units higher 
than 3.1, and supported the presence of a hydroxyl at C-3 in 3.3a instead of the C-3 
ketone moiety in 3.1. The ^-N M R  spectrum of 3.3a (Table 3.2) gave a signal at 5 3.28 
(dd, 7=10.1, 4.7 Hz) which was in agreement with a P-oriented hydroxyl group at C-3 
(Herz et al., 1985). Nearly identical proton signals due to the side-chain o f 3.3a, in 
particular the triplet due to H-24 at 8 2.69 (7=6.1 Hz), indicated that 3.1 and 3.3a must 
have the same side-chain. As in the case of compound 3.1, 3.3a exhibited a 'H-NMR
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spectrum with seven methyl absorptions between 8 0.80 and 1.30, and cyclopropane 
doublets appeared at 8 0.33 and 0.55 (J=4.2 Hz). l3C-NMR data obtained at 62.5 MHz 
(Table 3.3) and DEPT experiments confirmed the presence o f seven methyls, and instead 
of the C-3 carbonyl absorption at 8 216.5 in 3.1, in 33a  a signal typical of a hydroxyl-
bearing carbon absorption appeared at 8 78.8 (C-3). Further lH-and 13C-NMR signals of 
3.3a were assigned by inspection and spectral comparison with 3.1 and a previously 
isolated mixture of epimers (De Pascual Teresa et al., 1987), which differed only in the 
configuration of the epoxide ring at C-24.
Acetylation of 33a gave the monoacetate 3.3b, C32H52O3, which was indicated 
by a three-proton methyl singlet at 8 2.05 in the 1H-NMR spectrum. In addition, H-3 was 
shifted from 8 3.28 in 33a to 4!56 in 33b, supporting the presence of an acetate group at
C-3 in 3.3b. The 13C-NMR spectrum (Table 3.2) of 33b  differed from 33a only in the 
presence of two additional signals, a singlet at 8 170.9 and a quartet at 8 21.3, which 
correspond to the acetate carbonyl and methyl, respectively. All other carbon signals 
were very similar to those of 33a and peak assignments of 33b were made by 
correlation with 3.3a and related compounds reported in the literature (De Pascual Teresa 
et al., 1987; Anjaneyulu et al., 1985; Barik et al., 1994; Takaishi et al., 1987).
Chemical correlation of alcohol 33a with ketone 3.1 was first attempted by 
oxidation of 33a with pyridinium chlorochromate (PCC) (Mendes et al., 1994). 
However, this reagent not only oxidized the C-3 hydroxyl group of 33a but also affected 
the C24-C-25-epoxide function leading to the fragmentation product 3.5, C27H42O2, the 
structure of which was supported by mass spectral, l3C-NMR, and DEPT data. The mass
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spectrum of 3.5 gave a parent peak at m r 398 and, as in 3.1, loss of the side-chain gave a 
peak at m z  313. The compound showed IR bands at 1704 and 1726 (sh) cn r1 
corresponding to two carbonyl absorptions. The !H-NMR spectrum of 3.5 indicated the 
presence of only five methyl groups, with the methyl absorptions corresponding to H-26 
and H-27 in 3.1 being absent in 3.5 (Table 3.2). A triplet at S 9.78 (7=1.8 Hz) was 
assigned to an aldehyde proton (H-24) and the two diagnostic cyclopropane doublets 
appeared at 8 0.59 and 0.79 (7=4.2 Hz). When compared with data for compound 3.1,
the 13C-NMR spectrum of 3.5 indicated the loss of three carbons (C-25, C-26, and C-27). 
Instead, an aldehyde signal appeared at 5 203.3, which was assigned to C-24. Also, 
carbon signals of the adjacent positions C-22 (8 41.4) and C-23 (8 28.5) were shifted 
downfield in 3.5 relative to 3.1 due to the deshielding effect o f the aldehyde carbonyl (C-
24). All other 13C-NMR spectral signals of 3.5 were nearly identical to those of 3.1, with 
assignments being based on comparison with the analog absorptions of 3.1 and literature 
values reported for structurally related compounds (Jakupovic et al., 1991; De Pascual 
Teresa et al., 1987). Selective oxidation of 3.3a with RUCI3 and NaI04 (Ashby et al., 
1981) provided 3.1 which confirmed that the stereogenic center C-24 in 3.3a also has the 
R configuration. Therefore 3.3a differs from 3.1 only by the presence of a 3 p-hydroxyl 
moiety instead of a keto group (Jakupovic et al., 1991; Herz et al., 1985).
Compound 3.4, C30H48O2, showed IR absorptions at 1630 (ketone) and 3435
(hydroxyl) cm"1. When compared with 3.1, its ^-N M R  spectrum (Table 3.2) lacked the 
diagnostic triplet at 8 2.69 corresponding to H-24 of the epoxide moiety. Instead, two 
additional signals were present in 3.4: a broadened doublet at 8  4.48 (H-23) and a doublet
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of doublets at 8 5.19 (H-24), which were allylically coupled to two broadened methyl 
singlets absorbing at 8 1.69 and 1.71. This indicated the absence of an epoxide and 
strongly suggested the presence of a double bond in the side-chain of 3.4. The diagnostic 
cyclopropane methylene proton doublets at 8 0.57 and 0.78 in 3.1 were also absent in 3.4. 
Instead, compound 3.4 contained eight methyl signals, indicating one additional methyl
group, when compared with 3.1. The l3C-NMR spectrum of 3.4 (Table 3.2) and DEPT 
experiments supported the absence of the cyclopropane ring at C-19. Furthermore, the 
presence of a C-3 keto group (5 217.7), eight methyl quartets and four olefinic carbons 
was established. Spectral comparison with literature values suggested a lanostadiene 
type skeleton (Takaishi et al., 1987). The mass spectrum gave a molecular ion peak at 
m z  440 and the typical [M-side-chain]+ peak at m z 313. NMR spectral assignments of 
3.4 were made by spectral comparison with data described in the literature for 
structurally closely related compounds (De Pascual Teresa et al., 1987; Bank et al., 
1994). The molecular structure of 3.4 (Figure 3.1) was determined by single-crystal X- 
ray diffraction techniques. Table 3.4 summarizes the crystallographic data and its 
coordinates are listed in Table 3.6. A negative Cotton effect in the CD spectrum was 
observed near 295 nm, which confirmed the absolute stereochemistry shown in structural 
formula 3.4 (Herz et al., 1985).
Details of data collection and refinements made in the X-ray diffraction analysis 
o f 3.1 and 3.4 are given in Table 3.4. Figure 3.1 illustrates the a-oriented epoxide at C- 
24-C-25 and a P-cyclopropane ring fused at C-9-C-10 in 3.1 and the OH group at C-23 
and C-8=C-9 double bond in 3.4. The C8=C9 distance in 3.4 is 1.352(3) A. The quality
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of the crystal o f 3.4 was much higher than that of 3.1, and thus the precision of the 
determination was also much higher. This is apparently a result of hydrogen bonding in 
3.4. The OH group 0-2 is engaged in a linear, intermolecular hydrogen bond with
carbonyl oxygen 0-1  (at 1+x, y, 1+r) as acceptor. The 0 —0  distance is 2 .886(2 ) A, and 
the angle about the H atom is 173(3).
A search of the Cambridge Crystallographic Database (Allen et al., 1983) yielded 
no previous crystal structure determinations for triterpenes with the cycloartane or 
lanostadiene skeletons having an epoxide at C24-C25. The compounds most closely 
related to 3.1 for which crystal structures have been determined are 3-oxo-24-cycloarten- 
21-oic acid (Nishizawa et al., 1989) and argentatin C, (Romo de Vivar et al., 1990), 
which differ from 3.1 only by having a glycol at C-24-C-25 rather than an epoxide, and 
by having a P-OH group at C-16. The compounds most closely related to 3.4 for which 
crystal structures have been determined are euphyl acetate and tirucallyl acetate (Nes et 
al., 1984). Both have acetate substituents at C-3 and lack the OH group at C-23.
In a radiorespirometric bioassay against M. tuberculosis (H37Rv) (Heifets et al., 
1991), both triterpenes 3.1 and 33a showed minimum inhibitory concentrations (MICs) 
of 8 pg/ml while compounds 3.4 and 33b had MIC values of 64-128 pg/'ml and >128 
pg/ml, respectively (Table 3.7). Correlations of structural features and the MICs o f the 
four triterpenes suggest that the presence of the C-3 keto and/or P-hydroxy group, the 
cyclopropane ring and the epoxide moieties as in 3.1 and 33a  seem to play a major role 
in the in vitro antituberculosis activity. Both the cyclopropane and epoxide functions are 
absent in triterpene 3.4, resulting in its loss of activity (MIC 64-128 pg/ml). Also, the
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loss of activity by the presence of a C-3 acetoxv group (MIC of 3.3b >128 pg/ml) 
strongly supports our suggestion that either a free hydroxyl or a keto group at C-3 in 3.1 
or 3.3a is required for significant activity. Argentatine A (3.6) and B (3.7) were also 
tested against M. tuberculosis due to their structural and biosynthetic similarities to the 
bioactive natural triterpenes (Jakupovic et al., 1991). The lack of significant activity of 
compounds 3.6 and 3.7 with MIC’s >128 pg/ml (Table 3.7) allows us to suggest that the 
epoxide ring present in the side-chain of the active triterpenes 3.1 and 3.3a appears to be 
essential for the in vitro antituberculosis activity. These preliminary structure-activity 
data require further verification by testing structurally related triterpenes to leam about 
the essential active regions necessary for significant antituberculosis activities. The 
clinically active triterpene fusidic acid was also tested against M. tuberculosis for 
comparison. In our radiorespirometric bioassay, its MIC o f 4 pg/ml was lower than the 
previously reported value of 32-64 pg/ml (Hoffner et al., 1990). Cytotoxicity results 
(Table 3.7) for a mammalian cell line indicate that the active triterpenes 3.1 and 3.3a 
have IC50 values of 71.8 and 39.8 M-g/ml, respectively, while the inactive triterpene 3.4 
has an IC50 of 103.6 pg/ml, suggesting some degree of selective toxicity for M. 
tuberculosis.
3 J  Experimental
General Experimental Procedures. *H- and I3C-NMR spectra were recorded in 
CDCI3 on a Bruker AM 250 MHz spectrometer. Mass spectra were obtained on a 
Hewlett-Packard 5971A GC-MS, or a TSQ70 FAB mass spectrometer. IR spectra were
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run on a Perkin-Elmer 1760X spectrometer as a film on KBr plates. Vacuum-liquid 
chromatographic (VLC) separations were carried out on silica gel (MN Kieselgel).
Plant Material. B. frutescens was collected in May, 1994 in a brackish 
environment about one mile inland from the Gulf of Mexico at Grand Isle, Louisiana 
(N.H. Fischer No. 501; voucher deposited at LSU Herbarium).
Extraction and Isolation. Air-dried flowers (910 g) of B. frutescens were 
extracted at room temperature with 1700 ml of hexane. Evaporation of the solvent in 
vacuo provided 10.1 g of crude extract. The plant residue was then extracted with 
CH2C12, (2x1800 ml for 24 h) to yield, after removal of solvent, 19.8 g of crude CH2C12 
extract. Biological screening of the extracts led to the investigation of the CH2C12 
extract, 9.8 g of which was adsorbed on 8 g of Si gel and placed onto a VLC column (4 
cm in diameter and 30 cm long) packed with 70 g of Si gel (Coll et al., 1986). The 
extract was separated into eight fractions using a gradient of hexane-EtOAc-MeOH of 
increasing polarity. Table 3.1 lists the amounts and proportions of solvents used in the 
fractionations as well as the percent inhibition of each fraction against M. tuberculosis. 
Based on these results, fractions 2-4 were used for further isolation of the active 
constituents.
Fraction 3 (1.8 g) was adsorbed on 3 g of silica gel and placed onto a VLC 
column (3 cm in diameter and 25 cm long), packed with 40 g of Si gel and 
chromatographed using 11x100 ml hexane-EtOAc mixtures of increasing polarity. 
Altogether 53 fractions (20 ml each) were collected. Fractions 11-14 (hexane-EtOAc, 
95:5) were evaporated to provide 145 mg of crystalline 3.1. Fractions 21-23 
(hexane:EtOAc, 92:8) gave 30 mg o f crystalline 3.4. Fractions 28-29 (hexane:EtOAc,
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9:1) slowly crystallized from a mixture of hexane and EtOAc (85:5) to yield 41 mg of 
3.3a.
(24/?)-24,25-Epoxycycloartan-3-one (3.1). colorless crystals; C30H48O2; mol wt 
440.717; mp 119-122 °C; IR o max (KBr), 1708 (C=0) c m 1; CD nm (e) 212 (-1.8), 225 
(-18.2), 236 (-0.5), 298 (-32.6), 401 (-0.1) (c 0.0019; MeOH); lH-NMR spectral data see 
Table 3.2; 13C-NMR spectral data see Table 3.3; EIMS (70 eV) m z  [M]' 440 (7), [M - 
Me]" 425 (4), [M - H20]" 422 (1), [M - side-chain]" 313 (40), 302 (16), 175 (35), 163 (24),
[side-chain]" 127 (13), 121 (50), [127-H20]+ 109 (53), 107 (56), [127-M e-OHf 95 (100), 
81 (52), 69 (60), 55 (76), 43 (74).
(3(5r24/?)-24, 25-Epoxycycloartan-3-ol (3.3a). colorless crystals; C3oH5o0 2; mol 
wt 442.732; mp 101-103 °C; IR u max (KBr), 3387 (OH) cm-1; CD nm (e) 201 (-0.06), 
222 (+19.1), 244 (-0.01), 307 (-2.9), 396 (-0.03) (c 0.0005; MeOH); 'H-NMR spectral 
data see Table 3.2; l3C-NMR spectral data see Table 3.3; EEMS (70 eV) m z  [M-H20]"r 
424 (8), [M-Me-OHf 410 ( 10), [424-M ef 409 (18), [M-side-chain]+ 315 (9), 311 (20 ), 
[315-H2O f  297 (47), 260 (10), 258 (17), 241 (14), 227 (14), 203 (48), [side-chain-H.O]^ 
109 (64), 107 (100), 91 (79), 81 (91), 79 (78), 69 (69), 55 (98.6), 43 (99); FABMS m z
[M]+ 442.6, [M-H]+ 441.7, [M-OH]+ 425.5, [M-Me-H2OJ+ 409.7.
(23/?)-3-Oxolanosta-8,24-dien-23-oI (3.4). colorless crystals; C3oH4s0 2; mol wt 
440.717; mp 73-75 °C; IR u max (KBr), 1630 (C=0), 3435 (OH) cm*1; CD nm (e) 215 
(0.0), 227 (-4.4), 275 (0.0), 311 (-3.7), 369 (-0.1), (c 0.0005; MeOH); *H-NMR spectral 
data see Table 3.2; 13C-NMR spectral data see Table 3.3; EIMS (70 eV) m z [M-OH]+
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423 (3), [M-H2O f  422 (8 ), [423-Mf 408 (4), [422-M]+ 407 (14), [M-side-chain]* 313
(16), 271 (13), 257 (13), [side-chainf 127 (1), [127-OH]+ 110 (12), [127-H20 f  109 
(100), 81 (50), 69 (29), 67 (35), 55 (41), 43 (31), 41 (31).
Acetylation of 3.3a. Compound 3.3a (20 mg) was dissolved in 1 ml of pyridine. 
After addition of 1 ml of Ac20  the mixture was allowed to react at room temperature for 
12 h. After removal of the reagents in vacuo the residue was separated by VLC (2 cm 
inner diameter column, 8 g of silica gel) using a gradient elution with hexane and 
hexane-EtOAc mixtures of increasing polarity. This yielded 11 mg of pure crystalline 
33b: colorless crystals; C32Hs20 3 ; mol wt 484.37; mp 161-163 °C; IR u max (KBr),
1726 (C=0) cm '1; CD nm (e) 207 (0.4), 226 (-6.56), 257 (0.0), (c 0.0012; MeOH); lH- 
NMR spectral data see Table 3.2; 13C-NMR spectral data see Table 3.3; EIMS (70 eV) 
m z  [M f 484 (1), [M-AcOH]+ 424 (2), [424-Me]+ 409 (2), 302 (4), [424-side-chain]+ 
297 (3), 175 (20), 161 (13), 135 (25), [side-chainf 127 (10), 107 (35), 95 (39), 69 (42), 
59(15), [Ac]+ 43 (100).
Pyridinium Chlorochromate (PCC) Oxidation of 33a  to 3.5. Compound 3 3 a  
(48 mg), dissolved in 3 ml of CH2C12, was added to a solution of PCC (100 mg) in 
CH2C12 (25 ml) and the mixture was allowed to react for 1 h. After addition of 10 ml of 
Et20 , the reaction mixture was adsorbed onto silica gel and separated by VLC (2.3 cm 
inner diameter column, 6 g o f silica gel) using a gradient elution of hexane or hexane- 
EtOAc of increasing polarity to yield 9 mg of pure, crystalline 3.5: gum; C27Hs20 2; mol
wt 389.63; IR u max (KBr) 1704 (C=0), 1726 (C=0 sh) cm '1; 'H-NMR spectral data see
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Table 3.2; 13C-NMR spectral data see Table 3.3; EIMS (70 eV) m z [M]~ 398 (11), [M- 
CH3]+ 383 (7), [M-H20 ]+ 380 (7), [380-M ef 365 (3), [M-side-chainf 313 (27), 175
(39), 161 (49), 147(36), 133 (49), 121 (62), 107 (71), 95 (98), [side-chainf 85 (37), 81 
(73), 67 (74), 55(100).
RuCl3/NaI0 4  Oxidation of 3.3a to 3.1. To a solution of 47.4 mg of 33a in 2 ml 
CH3CN, 2 ml CCI4 and 3 ml H20 , 85.6 mg (4 equivalents) of sodium metaperiodate 
were added (Ashby et al., 1981). To this biphasic solution l.l mg (4.1 mol %) o f  
ruthenium trichloride hydrate was added and stirred magnetically for 8 h while 
monitoring the reaction by TLC. At completion of the reaction, 10 ml of CH2CI2 were 
added to this solution and the phases separated. The aqueous layer was extracted three 
times with a total of 30 ml of CH2C12. The organic extracts were combined, dried 
(MgSC>4), and concentrated. The residue was diluted with 20 ml of ether and filtered 
through Celite (Ashby et al., 1981). The remaining material was adsorbed onto silica gel 
and separated by VLC, to yield 11.3 mg of pure 3.1.
X-Ray Crystallographic Analysis. (Atomic coordinates reference) Intensity 
data for 3.1 and 3.4 were collected on an Enraf-Nonius CAD4 diffractometer equipped 
with CuKa radiation (A.=l .54184 A), and a graphite monochromator, by ©-20 scans o f  
variable rate. Data reduction included corrections for background, Lorentz, polarization, 
decay, and absorption effects. Absorption corrections were based on vp scans, and linear 
corrections were made for decay. The structures were solved by direct methods and 
refined by full-matrix least squares, treating non-hydrogen atoms anisotropically, using 
the Enraf-Nonius MolEN programs (Fair, 1990). Hydrogen atoms were placed in
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calculated positions, except for that of the OH group of 3.4, which was refined 
isotropically. Details of data collections and refinements are given in Table 3 .4.
Radiorespirometric Bioassays. All compounds were solubilized at 10.24 mg'ml 
in DMSO, filter sterilized and stored at -80 °C until used. Subsequent dilution was done 
in DMSO. Fifty microliters of each solution were added to 4 ml BACTEC 12B broth 
(Becton Dickinson, Towson, MD) to achieve the desired final concentrations.
MIC’s were performed in the BACTEC 460 essentially as described by Heifets 
(Heifets et al., 1991). M  tuberculosis H37R.V was cultured in 4 ml BACTEC 12B broth 
until a daily growth index (GI) of 400-999 was reached. One tenth ml of this was used to 
inoculate 4 ml fresh BACTEC 12B medium containing test compounds. Additional 
controls diluted 1:100 were also included. Cultures were incubated at 37 °C and the GI 
determined daily starting on the third day o f incubation. Percent inhibition o f fractions 
was calculated as (1-GI test sampIe/GI undiluted control) x 100 on the day which the 
undiluted controls reached peak values of 999. The minimum inhibitory concentration 
(MIC) of pure compounds was defined as the lowest concentration of drug which 
effected a daily GI increase and final GI lower than the 1:100 diluted control vial 
readings when the 1:100 GI was >30. This corresponds to the concentration which 
inhibited the growth of 99% of the organisms. Experiments were usually completed 
within 10 days.
Cytotoxicity Assay. Test compounds were dissolved at 20-40 mg/ml in ethanol. 
Geometric three-fold dilutions were performed in growth medium M l99 [Gibco, Grand 
Island, NY] + 5% fetal bovine serum [HyClone, Logan, UT] +25 mM N-2- 
hydroxyethylpiperazine-jV’-2-ethanesulfonic acid [HEPES, Gibco] + 0.2% NaHCOj
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[Gibco] -j- 2 mM glutamine [Irvine Scientific, Santa Ana, CA] to achieve final 
concentrations ranging from 4.2 to 400 pig/ml. Final ethanol concentrations did not 
exceed 1% v/v. Drug dilutions were distributed in duplicate in 96-well tissue culture 
plates (Becton Dickinson Labware, Lincoln Park, NJ) at a volume of 50 nL/well. An 
equal volume containing 5 x 103 log phase Vero cells (CCL-81; American Type Culture 
Collection, Rockville, MD) was added to each well and the cultures were incubated at 37 
°C in an atmosphere of 5% CCL in air. After 72 h, cell viability was measured using the 
CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (Promega Corp., Madison, 
WI) according to the manufacturer’s instructions. Absorbance at 490 nm was read in a 
BioRad Model 3550 microplate reader (Hercules, CA). The IC50 is defined as the 
reciprocal dilution resulting in 50% inhibition o f the Vero cells. Maximum cytotoxicity 
(100%) was determined by lysing the cells with sodium dodecyl sulfate (Sigma Chemical 
Co., St. Louis, MO).
Table 3.1. Inhibitory Activity o f Borrichia frutescens Fractions (Flowers, CHiCL 
Extract) against Mycobacterium tuberculosis (H3 7 RV)
fraction0 % hexane % EtOAc % MeOH
percent inhibition
33 pg/ml 100 ng/ml
1.................................... 100 _ __ 31 23
2 .................. 95 5 — 95 95
3.................. 80 20 — 97 97
4.................. 50 50 — 95 96
5.................. 20 80 — 27 48
6 .................. — 100 — 26 58
7.................. — 50 50 21 19
8.................. — 100 24 19
°100 ml of solvent.
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Table 3.2. 'H-NMR Spectral Data of Compounds 3.1, 3.3a, 3.3b,3.4, and 3.5 (250 
MHz, CDCljf
proton compound
3.1 3.3a 33b 3.4 3.5
H-2a............ 2.26 m 2.39 ddd 2.31m
(3.8,6.8, 15)
H-2b........... 2.32 m — — 2.59 ddd 2.72ddd
(7.0,11,15) (6.7, 14, 14)
H-3.............. — 3.28 dd 4.56 dd — —
(10.1,4.7) (10.1,5.2)
H-18........... 0.89 s 0.80 s 0.84 s 0.74 s 0.91s
H-19a.......... 0.57 d 0.33 d 0.36 d 1.06 s 0.59d
(4.4) (4.3) (4.3) (4.2)
H-19b......... 0.78 d 0.55 d 0.57 d — 0.79d
(3.6) (4.1) (4.1) (4.2)
H-21........... 0.89 d 0.88 d 0.87 d 0.98 d 0.89d
(5.5) (6.2) (6.8) (6.4) (6.2)
H-23........... — — — 4.48 ddd —
(2.7,9.1,9.1)
H-24........... 2.69 dd 2.69 dd 2.69 dd 5.19 dd 9.78dd
(6.2) (6.1) (5.9) (2.2, 9.1) (1.8,1.8)
H-26........... 1.26 s 1.26 s 1.27 s 1.69 s —
H-27........... 1.30 s 1.30 s 1.31 s 1.71 s —
H-28........... 1.04 s 0.96 s 0.88 s 1.09 s 1.05s
H-29............ 1.09 s 0.96 s 0.89 s 1.12s 1.1 Is
H-30........... 0.90 s 0.89 s 0.96 s 0.88 s 1.00s
H-2'........... — — 2.05 s — —
a Expressed as 8 values in ppm, with J  values in Hz in parentheses.
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Table 3.3. 13C-NMR Spectral Data of Compounds 3.1,3.3a, 33b, 3.4, and 3.5 (62.5 
MHz, CDCl3f
carbon compound
3.1 33a 33b 3.4 3.5
C -l............. 33.41 32.01 31.61 36.1 t 33.61
C-2............. 37.4 t 30.41 26.5 t 34.6 t 37.71
C-3............. 216.5 s 78.8 d 80.7 d 217.7 s 216.7 s
C-4............. 50.2 s 40.5 s 39.5 s 47.4 s 50.5 s
C-5............. 48.4 d 48.0 d 47.8 d 50.9 d 48.6 d
C-6............. 21.51 21.11 20.91 19.4 t 21.71
C-7............. 28.11 28.2 t 28.2 t 28.3 t 28.3 t
C-8............. 47.9 d 47.1 d 47.2 d 133.2 s 48.1 d
C-9............. 21.1 s 20.0 s 20.1 s 133.8 s 21.3 s
C-10........... 26.0 s 26.0 s 26.0 s 36.9 s 26.2 s
C -ll........... 25.81 26.11 25.81 21.1 t 26.11
C-l 2........... 35.51 35.5 t 35.5 t 26.3 t 35.71
C-13........... 45.3 s 45.3 s 45.3 s 44.6 s 45.6 s
C-14........... 48.7 s 48.8 s 48.9 s 50.0 s 49.0 s
C-15........... 32.81 32.91 32.9 t 31.01 33.01
C-16........... 26.71 26.41 26.8 s 30.91 26.91
C-l 7........... 52.2 d 52.1 d 52.2 d 51.3 d 52.4 d
C-l 8........... 18.1 q 18.0 q 18.0 q 18.1 q 18.2 q
C-l 9........... 29.51 29.91 29.81 18.7 q 29.71
C-20........... 35.8 d 35.8 d 35.9 d 33.1 d 35.9 d
C-21........... 18.3 q 18.3 q 18.3 q 18.7 q 18.3 q
C-22........... 32.61 32.91 32.61 44.4 t 41.4 t
C-23........... 25.61 25.61 25.71 66.0 d 28.5 t
C-24........... 64.7 d 64.8 d 64.8 d 129.1 d 203.3 d
C-25........... 58.3 s 58.4 s 58.4 s 135.3 s —
C-26........... 18.7 q 18.7 q 18.8 q 24.2 q —
C-27........... 24.9 q 24.9 q 24.9 q 26.2 q —
C-28........... 22.2 q 25.4 q 25.4 q 25.7 q 22.4 q
C-29........... 20.7 q 14.0 q 15.1 q 15.9 q 21.0 q
C-30........... 19.2 q 19.3 q 19.3 q 21.3 q 19.5 q
C -l'............ — — 170.9 s — —
C-2'............ ---- — 21.3 q - - - -
“Peak multiplicities were determined by heteronuclear multipulse programs (DEPT); 
s = singlet, d = doublet t = triplet, q = quartet.
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Table 3.4. Crystallographic Data of Triterpenes 3.1 and 3.4
compound 3.1 compound 3.4
Formula C30H48O2 C30H48O2
Molecular weight 440.7 440.7
Space group Monoclinic P2\ Monoclinic P2i
a (A) 7.527(1) 11.926(1)
b (A) 9.127(1) 7.479(1)
c (A) 19.664(3) 16.203(2)
P(°) 97.60(1) 112.25(1)
V(A3) 1339.0(6) 1337.6(6)
Dc (g cm3) 1.093 1.094
Z 2 2
u CuKa (cm 1) 4.5 4.7
Temperature (°C) 23 22
Crystal dimensions (mm) 0.25x0.22x0.05 0.60x0.40x0.12
Crystal Colorless plate Colorless lath
0 range (°) 2-75 2-75 (hemisphere)
Unique data 2935 5440
Observed data 1610 5202
Criterion for observed I>lo(I) I>3ct(I)
Refined variables 289 293
Intensity decay (%) 14.0 4.3
Min. rel. tranmission (%) 80.9 93.7
R 0.100 0.055
R-w 0.077 0.075
Max. resid. density (eA*3) 0.31 0.64
Min. resid. density (eA-3) -0.10 -0.13
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Table 3.5. Coordinates and Equivalent Isotropic Thermal Parameters for (24/?)-24,25- 
Epoxycycloartan-3-one (3.1 )a
atom .r y z 5eq(A2)
O -l ...................... 0.5791(6) 0 1.0479(2) 10.4(2)
0 -2 .................. 0.0685(9) -0.105(1) 0.2595(3) 12.5(3)
C -l.................. 0.3169(8) 0.026(1) 0.8864(3) 6.7(3)
C-2.................. 0.3696(9) 0.089(1) 0.9576(3) 6.8(2)
C-3.................. 0.5535(9) 0.040(1) 0.9902(3) 6.6(2)
C-4.................. 0.7034(8) 0.053(1) 0.9443(3) 5.8(2)
C-5.................. 0.6380(8) 0.005(1) 0.8711(3) 6.4(2)
C-6.................. 0.7789(8) 0.019(1) 0.8223(3) 7.4(3)
C-7.................. 0.7061(9) -0.048(1) 0.7531(3) 7.4(3)
C-8.................. 0.5513(8) 0.043(1) 0.7178(3) 5.3(2)
C-9.................. 0.4072(7) 0.077(1) 0.7630(3) 4.7(2)
C-10................ 0.4564(8) 0.0646(9) 0.8411(3) 4.3(2)
C - l l ................ 0.2101(8) 0.040(1) 0.7336(3) 5.6(2)
C-l 2................ 0.1564(8) 0.051(1) 0.6570(3) 5.5(2)
C-13................ 0.3146(7) 0.0814(9) 0.6143(3) 3.6(2)
C-l 4................ 0.4720(8) -0.0134(9) 0.6471(3) 4.3(2)
C-l 5................ 0.6052(9) 0.004(1) 0.5925(3) 6.8(2)
C-16................ 0.4874(9) 0.020(1) 0.5241(3) 6-9(3)
C-17................ 0.2878(7) 0.0259(9) 0.5392(3) 4.2(2)
C-l 8................ 0.3560(8) 0.244(1) 0.6195(3) 4.9(2)
C-l 9................ 0.4355(8) 0.209(1) 0.8070(3) 5.7(2)
C-20................ 0.1757(9) 0.112(1) 0.4842(3) 5.5(2)
C-21................ -0.023(1) 0.114(1) 0.4964(4) 7.0(3)
C-22................ 0.1805(9) 0.028(2) 0.4118(3) 11.3(4)
C-23................ 0.091(1) 0.091(2) 0.3577(4) 12.4(5)
C-24................ 0.147(1) 0.018(2) 0.2911(4) 12.3(4)
C-25................ 0.038(1) 0.043(1) 0.2229(4) 11.4(4)
C-26................ -0.146(2) 0.088(2) 0.2174(7) 17.0(5)
C-27................ 0.140(2) 0.048(2) 0.1638(5) 16.7(5)
C-2 8................ 0.426(1) -0.173(1) 0.6496(4) 6.8(2)
C-29................ 0.857(1) -0.042(1) 0.9754(4) 9.0(3)
C-30................ 0.760(1) 0.212(1) 0.9493(4) 8.1(3)
a Figures in parentheses are ESD.
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Table 3.6. Coordinates and Equivalent Isotropic Thermal Parameters for (23/?)-3- 
Oxolanosta-8,24-dien-23-ol (3.4)a
atom .T y - #eq(A2)
0-1................... 0.1260(2) 0 0.4697(1) 5.32(4)
0-2................... 0.9858(1) -0.1580(3) 1.29915(9) 4.74(4)
C -l................... 0.3570(2) 0.1313(3) 0.6674(1) 3.91(4)
C-2................... 0.2277(2) 0.1657(3) 0.6007(1) 4.38(5)
C-3................... 0.1714(2) -0.0016(3) 0.5509(1) 3.55(4)
C-4................... 0.1745(2) -0.1674(3) 0.6049(1) 3.38(4)
C-5................... 0.3047(2) -0.1875(3) 0.6787(1) 3.09(3)
C-6................... 0.3180(2) -0.3464(3) 0.7402(2) 4.41(5)
C-7................... 0.4512(2) -0.3891(3) 0.7886(2) 4.48(5)
C-8................... 0.5303(2) -0.2287(3) 0.8222(1) 3.13(4)
C-9................... 0.4920(2) -0.0602(3) 0.7960(1) 2.96(3)
C-10................. 0.3615(2) -0.0184(3) 0.7335(1) 3.10(3)
C-l 1................. 0.5769(2) 0.0979(3) 0.8297(1) 3.91(4)
C-l 2................. 0.7006(2) 0.0658(3) 0.9056(1) 4.15(5)
C-13................. 0.7062(1) -0.1103(3) 0.9542(1) 2.95(3)
C-l 4................. 0.6613(2) -0.2593(3) 0.8818(1) 3.14(4)
C-15................. 0.6918(2) -0.4288(3) 0.9391(2) 5.08(6)
C-l 6................. 0.8132(2) -0.3864(3) 1.0152(1) 4.17(5)
C-l 7................. 0.8335(2) -0.1816(3) 1.0160(1) 3.23(4)
C-l 8................. 0.6243(2) -0.0952(4) 1.0071(1) 4.29(4)
C-l 9................. 0.2983(2) 0.0462(4) 0.7962(2) 5.37(6)
C-20................. 0.8933(2) -0.1043(3) 1.1105(1) 3.68(4)
C-21................. 0.9174(2) 0.0952(4) 1.1108(2) 5.05(5)
C-22................. 1.0110(2) -0.2084(4) 1.1615(1) 4.90(5)
C-23................. 1.0750(2) -0.1614(4) 1.2601(1) 4.88(5)
C-24................. 1.1665(2) -0.3097(5) 1.3066(2) 6.22(7)
C-25................. 1.2792(2) -0.2982(7) 1.3619(2) 7.68(9)
C-26................. 1.3437(3) -0.1212(9) 1.3866(2) 10.9(1)
C-27................. 1.3502(3) -0.4605(8) 1.4067(2) 11.1(1)
C-28................. 0.7346(2) -0.2646(4) 0.8211(1) 5.28(5)
C-29................. 0.1461(2) -0.3306(3) 0.5435(2) 4.72(5)
C-30................. 0.0731(2) -0.1495(4) 0.6413(2) 4.88(5)
a Figures in parentheses are ESD.
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Table 3.7. Minimum Inhibitory Concentrations Against M. tuberculosis and IC50 Values 
Against Vero cells







fusidic acid 4 105.8
























Figure 3.1. Triterpenes isolated from B. frutescens
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ANTEVTYCOBACTERIAL ACTIVITIES OF DEHYDROCOSTUS LACTONE
AND ITS OXIDATION PRODUCTS *
* Reprinted with permission from Journal o f  Natural Products, in press. Unpublished 
work copyright 1997 American Chemical Society.
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4.1 Introduction
In a search for new structural types of antimycobacterial natural products, in vitro 
tests against M. tuberculosis o f a series of natural and semisynthetic guaianolide-tvpe 
sesquiterpene lactones were performed. Dehydrocostus lactone (4.1a), a major 
constituent of Saussurea lappa Clark (Asteraceae) (Romanuk et al., 1956; Lu et al., 
1996), gave MICs of 2 and 16 pg/ml against M. tuberculosis and M. avium, respectively. 
It was therefore of interest to leam whether epoxidation of the nonlactonic double bonds 
of 4.1a would result in derivatives with increased activity, since antimycobacterial 
triterpenes from B. frutescens correlated well with the presence of an epoxyprenyl group 
(Cantrell et al., 1996). The presence o f epoxides could possibly increase activity due to 
enzyme alkylation(s) of the epoxide(s) by essential nucleophiles (thiols and/or amino 
groups) at enzyme active sites o f the mycobacterium. Therefore, 4.1a was used as a 
starting compound for various oxidative modifications in an attempt to find sesquiterpene 
lactones with increased antimycobacterial activity.
4.2 Results and Discussion
Dehydrocostus lactone (4.1a) was previously isolated from costus root oil in our 
laboratory as described earlier (Lu et al., 1996). The reaction of a solution of 4.1a in 
CH2CI2 with 1.5 molar equivalents of m-chloroperbenzoic acid (m-CPBA) gave a mixture 
of reaction products, which were separated by vacuum-liquid chromatography (VLC), 
providing the monoepoxides 43a , 4.2, and 43b in the less polar fractions, followed by 
the more polar diepoxides 4.4a, 4.4b, and 4.4c.
Inspection of the ‘H-NMR spectrum of 43a indicated a monoepoxide that 
differed from 4.1a in the absence of the two olefinic methylene protons at C-l4 with
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singlets at 8 4.82 and 8 4.90. Instead, two mutually coupled doublets appeared at 5 2.75 
and 3.10 (J=4.9 Hz), suggesting epoxidation at the C-10( 14) position. This was 
supported by the 13C-NMR spectrum of 4.3a, in which the two olefinic carbon signals (C- 
10 and C-14) in 4.1a were replaced by signals corresponding to the oxygen-bearing C-10 
(5 65.1, s) and C-14 (8 48.4, t) in 43a. The stereochemistry of the epoxide ring was 
determined by NOESY spectroscopy with correlations being observed between H-14b 
and H-5a, suggesting a C-10 (i-epoxide. Further lH- and l3C- NMR assignments were 
made by inspection of COSY, HMQC, and HMBC spectra, and the chemical shifts 
obtained are summarized in Tables 1 and 2, respectively.
*H- and 13C-NMR analysis o f epoxide 43b also indicated epoxidation at C-l 0(14) 
based on similar reasoning to that described above for 4.3a. The stereochemistry of 43b 
was confirmed by NOESY spectroscopy, which showed interactions between H-6(3 and 
both epoxide protons at C-14, suggesting a C-10 a-epoxide. The application of 2D 
COSY, HMQC, and HMBC permitted all assignments in the lH- and 13C-NMR spectra, 
which are summarized in Tables 1 and 2, respectively.
The ’H-NMR. spectrum of compound 4.2 indicated that it differed from 4.1a in 
the absence of the olefinic methylene protons at C -l5. Instead, 4.2 exhibited mutually 
coupled oxirane methylene doublets at 8 2.84 and 3.36 (.7=4.5 Hz) which were absent in 
4.1a. The 13C-NMR data also indicated that the epoxide group in 4.2 could be placed 
between the C-4(15) positions. The stereochemistry at C-4 was determined by NOESY 
spectroscopy which indicated a strong NOE correlation between H-15b and H-6(3. 
Further support for a C-4a-epoxide was provided by reaction of 4.2 with excess m-CPBA 
to produce diepoxides 4.4b and 4.4c. Since the stereochemistry o f 4.4c was determined
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by single crystal X-ray diffraction, this conversion unambiguously established the oc- 
epoxide stereochemistry at C-4(15) in 4.2. *H- and I3C-NMR assignments o f 4.2 were 
based on inspection of COSY, HMQC, and HMBC spectra and are summarized in Tables 
1 and 2, respectively.
In the ’H- NMR spectrum of compound 4.4a, the olefinic H-14 and H-15 signals 
present in 4.1a were replaced by two sets of mutually coupled oxirane proton doublets at 
5 2.55 and 2.85 (.7=4.3 Hz) corresponding to H-14a and H-I4b and doublets (H-15a and 
H-15b) at 8 2.80 and 3.27 (.7=4.4 Hz), suggesting a C-10(14), C-4(15) diepoxide. The 
relative stereochemistry of the epoxide groups was unambiguously determined by single­
crystal X-ray diffraction. Its molecular structure is shown in Figure 4.1 and the X-ray 
crystallographic atomic coordinates are given in Table 4.5. The molecular structure 
indicated a C-4(15) P-epoxide while the C-10(14) epoxide oxygen is a-oriented. 
Compound 4.4a has been previously prepared from 4.1a as a mixture of C-10(14) 
epoxide epimers with an undefined stereochemistry of the products (Kalsi et al., 1979). 
‘H- and l3C-NMR spectra of pure 4.4a were assigned by various 2D NMR techniques 
and the spectral data are reported in Tables 1 and 2, respectively.
Examination of the *H- and I3C-NMR spectra of diepoxides 4.4b and 4.4c 
indicated that they represented C-l0(14), C-4(15) isomers based on arguments made 
above for 4.4a. The epoxide stereochemistry of compound 4.4b was determined by 
NOESY spectroscopy with correlations observed between H-6P and H-14b as well as 
between H-6P and H-15b, both indicating an a-orientation for the two epoxide oxygens. 
The relative stereochemistry of compound 4.4c was determined by single-crystal X-ray 
diffraction (Figure 4.1), which showed a C-4(15) a-epoxide and a C-10(14) p-epoxide.
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Therefore, the epimers 4.4b and 4.4c differed only in the configuration of the C-10(14) 
epoxide group. X-ray coordinates for 4.4c are listed in Table 4.6 and lH- and nC-NMR 
spectral assignments by various 2D NMR techniques for 4.4b and 4.4c are summarized in 
Tables 1 and 2, respectively.
3-Epizaluzanin C (4.1b) was prepared from 4.1a by a previously described 
method (Kalsi et al., 1984) using Se02 and /-BuOOH in CTLCL. The ‘H- and 13ONMR 
spectral data of 4.1b were in full agreement with reported values (Kalsi et al., 1983). 
Single-crystal X-ray crystallographic analysis of 4.1b (Figure 4.1) was performed and its 
atomic coordinates are listed in Table 4.4.
The crystal structures of 4.1b, 4.4a, and 4.4c are illustrated in Figure 4.1. Lactone 
4.1b is essentially isomorphous with dehydrocostus lactone (Fronczek et al., 1989), 
which lacks the OH group at 0 3 ,  despite the intermolecular hydrogen bonding by the 
OH group. That hydrogen bond is linear, and involves the lactone carbonyl oxygen 0-2 
as acceptor, having an 0 ...0  distance of 2.858(2) A and an angle about H of 179(3)°. 
While the conformations of the seven-membered and lactone rings in 4.1b and 
dehydrocostus lactone (4.1a) are nearly identical, the conformations of their other 5- 
membered rings differ as a result of the C-3-OH substitution. While this ring in 
dehydrocostus lactone has a distorted half-chair conformation, it has the envelope 
conformation with C-5 in the flap position in 4.1b.
The conformation of 4.4c is similar to that of 4.1b, with a twist-chair seven- 
membered ring having C-8 on the twist axis, and a half-chair lactone. Diepoxide 4.4a has 
two independent molecules in the asymmetric unit. Their conformations are nearly 
identical, but differ markedly from that o f 4.4c. Lactone 4.4a has its seven-membered
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ring in a distorted twist-chair with C-5 on the twist axis, and an envelope cyclopentane 
ring with C-4 at the flap position.
The MICs of the guaianolides were determined in radiorespirometric bioassays 
against Mycobacterium tuberculosis (H 3 7 R.V) and 4.1a and 4.1b were also tested against 
M. avium (Cantrell et al., 1996; Connell et al., 1994). The MICs against M. tuberculosis 
of dehydrocostus lactone (4.1a), its oxidative derivatives (4.2, 4.3a, 4.3b, and 4.4a-4.4c) 
and hydroxylated analogs (4.1b, 4.1c, 4.5, and 4.6) are listed in Table 4.7. The most 
active lactone 4.1a, with an MIC o f 2 pg/ml, is also the most lipophilic among this group 
of guaianolides. It is evident that the presence of a hydroxyl group at different positions 
of the guaianolide skeleton, as shown for 4.1b, 4.1c, 4.5, and 4.6, significantly reduces 
activity against M. tuberculosis. This might be due to the increase in polarity which 
possibly reduces transport through the outer lipid layer of the mycobacterium (Connell et 
al., 1994).
Since, in our previous study on cycloartane triterpenes from Borrichia frutescens, 
the presence of an epoxide group in the molecule significantly augmented the 
antituberculosis activity (Cantrell et al., 1996), mono- and diepoxide derivatives of 
dehydrocostus lactone (4.1a) were tested for their activity. Compared to 4.1a, the 
monoepoxides 4.2, 4.3a, and 43b showed significantly decreased activity against M. 
tuberculosis with MICs of 32, 32, and 64 jig/ml, respectively. The more polar diepoxides 
4.4a, 4.4b, and 4.4c exhibited MICs o f 64, 128, and 128 pg/ml, respectively, supporting 
the correlation between lipophilicity and antituberculosis activity within this guaianolide 
series.
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In addition to the correlation between lipophilicity and antituberculosis activity, 
there may also be a correlation of ring conformation with antituberculosis activity. It 
appears that diepoxides 4.4a and 4.4c not only differ in relative configuration of their 
epoxide rings, but also in their ring conformations, as indicated by their molecular 
structures based on X-ray data (Figure 4.1). Compound 4.4a has a one-fold lower MIC 
of 64 fig/ml and contains a seven-membered ring in a distorted twist-chair with C-5 on 
the twist axis. Compound 4.4c with an MIC of 128 pg/ml however contains a twist-chair 
seven-membered ring having C-8 on the twist axis.
In conclusion, the above structure-activity data permit us to suggest that the 
antimycobacterial activity of the tested guaianolides is not as strongly determined by the 
exocyclic methylene lactone moiety, as by polarity factors. Activity is most dramatically 
reduced when at least one hydroxyl group is present in the molecule (Compounds 4.1b, 
4.1c, 4.5, and 4.6). The successive replacement of double bonds with epoxide groups also 
caused a significant loss of activity with the more polar diepoxides being less active than 
the monoepoxide analogues. As contrasted by the activity of 4.4a and 4.4c, 
configurational and conformational influences seem to exist but appear to be of lesser 
importance. Since the most lipophilic guaianolde 4.1a gives the highest antimycobacterial 
activity, it can be concluded that activity is most strongly influenced by the polarity of a 
given molecule. Therefore, within this structurally related group of sesquiterpene lactones 
antimycobacterial activity is most likely controlled by the transport through the outer 
lipid layer of mycobacteria.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
88
43  Experimental
General Experimental Procedures. IH- and 13C-NMR spectra were recorded in 
CDCI3 on either a Bruker ARX 300 MHz spectrometer, or a Bruker AM 400 MHz 
spectrometer. Mass spectra were obtained on a Hewlett-Packard 5971A GC-MS. IR 
spectra were run on a Perkin-Elmer 1760X spectrometer as a film on KBr plates. 
Vacuum-liquid chromatographic (VLC) separations were earned out on TLC grade silica 
gel (MN Kieselgel) (Coll et al., 1986).
m-CPBA Oxidation of Dehydrocostus Lactone (4.1a). A solution of 980 mg of
dehydrocostus lactone (4.1a) in 20 ml CH2CI; was added to a solution o f 1.5 molar 
equivalents m-CPBA in 20 ml CH2CI2 and stirred in an ice bath for 2 h. The reaction 
mixture was washed twice with 40 ml 0.01 M NaOH soln and once with 40 ml of 
distilled H2O. TLC of the reaction mixture revealed at least five products. Accordingly, 
the crude mixture was adsorbed onto silica gel and chromatographed on a VLC column 
(3.5 cm i. d.) using solvent mixtures of hexane and EtOAc of increasing polarity. 
Fraction 7 (100 ml hexane-EtOAc, 88:12) contained 70 mg of 43a and fraction 8 
(hexane-EtOAc, 86:14) provided 138 mg of 4.2. Fraction 9 (hexane-EtOAc, 84:16) gave 
18 mg 43b, and fraction 11 (hexane-EtOAc, 4:1) contained 160 mg of crystalline 4.4a. 
Fraction 14 (hexane-EtOAc, 3:2) contained a mixture of two diepoxides which required 
further purification. Crude fraction 14 was adsorbed onto silica gel and 
rechromatographed on a VLC column (2.3 cm i.d.) using hexane or hexane-EtOAc 
mixtures of increasing polarity. Fraction 14-10 (50 ml hexane-EtOAc, 77:23) contained 
33 mg of 4.4b and fraction 14-11 (hexane-EtOAc , 76:24) gave 20 mg of crystalline 4.4c.
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Dehydrocostus lactone, 4ot(15)-epoxide (4.2). Gum; IR 1764 (C=0), 1637, 
1258, 1138 cm'1; ‘H-NMR, see Table 4.1; 13C-NMR, see Table 4.2; EIMS 7 0 e V m : 246 
[M f (12), 228 [M-H20 r (5 ) ,  217 (10), 188 (20), 161 (24), 150 (37), 124 (64), 91 (100), 
79 (67), 67 (43), 53 (81).
m-CPBA Oxidation of 4.2. Compound 4.2 (40 mg) was dissolved in 5 ml 
CH2C12 and added to 5 ml CH2C12 solution containing 4 equivalents m-CPBA. The 
reaction mixture was placed in an ice bath and stirred until TLC indicated that all 4.2 had 
reacted. The reaction was stopped after 2 h and worked up as described previously. 
Crude reaction products were chromatographed as indicated above to yield 16 mg of 4.4b 
and 11 mg of 4.4c.
Dehydrocostus Lactone, 10P(14)-epoxide (4.3a). Gum; IR v ^  1763 (C=0), 
1255, 996 cm'1; ‘H-NMR, see Table 4.1; 13C-NMR, see Table 4.2; EIMS 70 eV m :  246 
[M f (2), 228 [M -HiOf (7), 215 (44), 199 (9), 187 (12), 173 (14), 159 (21), 150 (99), 
123 (41), 105 (45), 91 (100), 79 (76), 53 (84).
Dehydrocostus Lactone, 10a(14)-epoxide (4.3b). Gum; IR v ^  1764 (C=0), 
1254, 995 c m 1; ‘H-NMR, see Table 4.1; I3C-NMR, see Table 4.2; EIMS 70 eV m :  246 
[M]+ (2), 228 [M-H2O f  (3), 216 (13), 200 (8), 171 (13), 159(12), 120 (36), 105 (40), 91 
(69), 80(100), 53 (47).
Dehydrocostus Lactone, 4P( 15), 10a( 14)-diepoxide (4.4a). Colorless crystals 
(hexane-EtOAc); mp 97 °C; IR vr a  1765 (C=0), 1254, 996, 867 c m 1; ‘H-NMR, see 
Table 4.1; 13C-NMR, see Table 4.2; EIMS 70 eV m z 262 [M]+ (1), 244 [M-H2O f  (2), 
231 (35), 214 (27), 203 (13), 185 (26), 173 (17), 159 (24), 105 (47), 91 (100), 79 (79), 67 
(59), 53 (80).
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Dehydrocostus Lactone, 4a(15),10a(14)-diepoxide (4.4b). Gum; IR 1763 
(C=0), 1258, 732 cm*1; ‘H-NMR, see Table 4.1; 13C-NMR, see Table 4.2; EIMS 70 eV 
m z  262 [M f (1), 261 (3), 247 [M-CH^f (D, 244 [M -H.Of (2), 231 (14), 215 (7), 203 
(19), 187 (13), 175 (20), 151 (29), 131 (33), 117 (44), 105 (47), 91 (100), 79 (67), 67 
(54), 53 (58).
Dehydrocostus Lactone, 4a(15),10f)(14)-diepoxide (4.4c). Colorless crystals 
(hexane-EtOAc); mp 133-135 °C; IR vmx 1765 (C=0), 1258, 999 cm*1; ‘H-NMR, see 
Table 4.1; 13C-NMR, see Table 4.2; EIMS 70 eV m z 262 [M f (1), 244 [M-H2O f  (2), 
231 (4), 215 (5), 203 (9), 151 (19), 131 (32), 117 (34), 105 (41), 91 (100), 79 (80), 67 
(76), 53 (99).
Selenium Dioxide Oxidation of Dehydrocostus Lactone (4.1a). Oxidation was 
performed as previously described and the crude product was purified by preparative 
TLC to yield pure 4.1b (Kalsi et al., 1984). The NMR data were essentially identical 
with values reported in the literature (Kalsi et al., 1984) and the molecular structure was 
unambiguously established by single-crystal X-ray diffraction.
Compounds 4.1c, 4.5, and 4.6. The natural sesquiterpene lactones 7a- 
hydroxydehydrocostus lactone (4.1c) (Fronczek et al., 1984), micheliolide (4.5) 
(Castaneda-Acosta et al., 1993), and pumilin (4.6)(Korp et al., 1982) have been obtained 
previously in our laboratory.
X-ray Crystallographic Analyses. Intensity data were collected for 4.1b, 4.4a, 
and 4.4c on an Enraf-Nonius CAD4 diffractometer with graphite-monochromated CuKa 
radiation (A.=1.54184 A) by o)-20 scans. Crystals of 4.4a were of considerably lower 
quality than those of the other two compounds, yielding broad diffraction peaks. The
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resulting structure determination is of lower precision, but is sufficient to establish the 
molecular structure. Two octants of data were collected for 4.4a and five octants for 
4.4c. Data reduction included corrections for background, Lorentz, polarization, decay 
(for 4.4a, 19%), and absorption (for 4.4c) effects. Absorption corrections were based on 
iy scans, vy Scans for 4.4c indicated no change in intensity with rotation about the 
diffraction vector. Crystals of 4.1b are isomorphous with dehydrocostus lactone; all 
atoms but C-3 of that structure were used as a beginning refinement model. Structures 
4.4a and 4.4c were solved by direct methods. Refinement was by full-matrix least 
squares, with neutral-atom scattering factors and anomalous dispersion corrections. All 
non-hydrogen atoms were refined anisotropically, while H atoms were treated as 
specified in Table 4.3. Refinement of the absolute structures o f 4.1b and 4.4c is 
consistent with the expected absolute configurations. Crystal data, details o f data 
collection and refinement, and final agreement indices for the three structures are given in 
Table 4.3.
Radiorespirometric Bioassays. Bioassays were performed essentially as 
described previously (Cantrell et al., 1996; Inderleid et al., 1996; Inderleid et al., 1995; 
Siddiqi et al., 1992). Experiments for A/, avium were usually completed within five days 
and those for M. tuberculosis in ten days.
4.4 References
Cantrell, C. L.; Lu, T.; Fronczek, F. R.; Fischer, N. H.; Adams, L. B.; Franzblau, S. G. J. 
Nat. Prod. 1996,59, 1131.
Castaneda-Acosta, J.; Fischer, N. H.; Vargas, D. J. Nat. Prod. 1993, 56, 90.
Cohn, D. L.; Bustreo, F.; Raviglione, M. C. Clin. Infectious Dis. 1997, 24 (Suppl. 1).
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Table 4.1. 300 MHz 'H-NMR Spectral Data for Compounds 4.2-4.4c Performed in
CDCl3a
proton 4.2 4 Ja 4.3b 4.4a 4.4b 4.4c
1 3.21 ddd 2.93 ddd 2.43 ddd 2.85 m 2.45 ddd 2.74 ddd
(8.1, 8.1, (4.0,9.0, (8.1,8.1, (8.7, 8.7, (8.1,8.1,
8.1) 9.0) 8.1) 8.7) 8.1)
2a 1.91 m 2.05 m 1.6-1.85* 1.66 m 1.70 m 1.68 m
2b 2.11 m 2.05 m 2.37 m 1.78 m 2.02 m 1.92 m
3a 1.69 m 1.86 ddd 
(6.5,9.0, 
14.5)
1.6-1.85* 1.49 m 1.60-1.78* 1.55-1.70*
3b 2.25 m 2.26 m 2.37 m 2.14 m 2.11-2.25* 2.02-2.12*
5 2.13 dd 2.64 dd 2.88 dd 2.69 dd 2.12m 2.22 dd
(8.1,11.0) (9.6,9.6) (9.3,9.3) (9.9, 9.9) (8.8, 10.7)
6 4.04 dd 4.08 dd 4.12 dd 4.10 dd 4.13 dd 4.23 dd
(8.8, 11.0) (9.6,9.6) (9.0, 10.2) (9.7, 9.8) (8.8, 11.2) (9.4, 9.4)
7 2.74 m 2.86 m 2.98 m 2.85 m 2.99 m 2.74 m









1.52 m 1.61 m
8b 2.25 m 2.22 m 2.27 dddd 
(4.3,6.0, 
6.0, 13.6)
1.45 m 2.29 m 2.11 m
9a 2.19 m 2.09 m 1.78 m 1.62 m 1.70 m 1.55-1.70*





1.91 m 2.10 m 2.02 m 2.02-2.12*
13a 5.46 d (3.4) 5.48 d (3.1) 5.53 d (3.1) 5.53 d (3.1) 5.51 d (3.1) 5.50 d (2.9)
13b 6.17 d (3.6) 6.19 d (3.6) 6.26 d (3.1) 6.24 d (3.5) 6.22 d (3.6) 6.22 d 
(3.67)
14a 4.94 s 2.75 d (4.9) 2.54 d (4.7) 2.55 d (4.3) 2.63 d (4.8) 2.60 d (4.8)
14b 4.97 s 3.10 d (4.9) 2.62 dd 
(1.2,4.5)
2.85 d (4.3) 2.68 d (4.8) 2.78 d (4.7)
15a 2.84 d (4.4) 5.00 s 5.02 d (  1.7) 2.80 d (4.4) 2.87 d (4.6) 2.86 d (4.4)
15b 3.36 d (4.5) 5.00 s 5.26 d( 1.8) 3.27 d (4.5) 3.33 d (4.4) 3.32 d (4.7)
a Coupling constants (Hz) are given in parentheses. 
* Observed due to overlap with other signals.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
93
Table 4.2. 75.4 MHz 13C-NMR Spectral Data for Compounds 4.2-4.4c Performed in
CDCha
Carbon 4.2 43a 43b 4.4a 4.4b 4.4c
1 46.8 d 46.6 d 46.5 d 43.8 d* 45.1 db 44.4 d
2 28.4 th 29.5 t* 25.5 t* 22.4 t 25.4 t 24.5 i*
3 31.4 tc 33.5 tc 32.2 tc 32.61 29.6 t 31.11
4 66.4 s 149.1 s 150.9 s 65.1 s 66.3 s 66.8 s
5 53.2 d 49.2 d 51.0 d 47.4 d* 52.8 d 52.8 d
6 81.8 d 82.0 d 84.1 d 81.1 d 81.1 d 81.6 d
7 45.8 d 44.9 d 44.7 d 44.5 d* 46.4 d* 47.4 d
8 29.8 tb 31.51* 28.81* 27.5 t 25.6 t 24.71*
9 33.1 tc 38.5 tc 33.4 tc 38.11 30.71 32.61
10 148.1 s 65.1 s 58.1 s 56.8 s 58.3 s 58.7 s
It 139.3 s 139.3 s 139.7 s 138.5 s 139.6 s 139.4 s
12 169.8 s 170.4 s 170.2 s 169.7 s 169.8 s 169.8 s
13 120.2 t 120.6 t 120.8 t 120.9 t 121.01 120.5 t
14 114.1 t 48.41 51.6 t 48.1 tc 50.3 tc 50.71
15 50.1 t 113.2 t 109.8 t 48.9 tc 54.6 tc 53.81
a Peak multiplicities were determined by DEPT experiments. 
b,c Data in same column are interchangeable.
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Table 4.4. Coordinates and Equivalent Isotropic Thermal Parameters for 4.1b
atom x V Bea'A Y
0-1 0.0798(1) 0.94141(7) 0.92791(7) 3.69(2)
0-2 0.2231(1) 1.09870(8) 0.96659(8) 4.89(2)
0-3 -0.0907(2) 0.51947(9) 0.8894(1) 6.45(3)
C-l -0.2437(2) 0.7666(1) 0.78196(9) 3.57(2)
C-2 -0.2973(2) 0.6747(1) 0.8548(2) 6.06(4)
C-3 -0.1310(2) 0.6345(1) 0.9026(1) 3.97(3)
0.0138(2) 0.70896(9) 0.86393(9) 3.24(2)
C-5 -0.0674(2) 0.81357(9) 0.82126(8) 2.94(2)
C-6 -0.0930(2) 0.90910(9) 0.89195(8) 2.91(2)
C-l -0.1695(2) 1.01729(9) 0.84877(9) 3.04(2)
C-8 -0.3672(2) 1.0285(1) 0.8588(1) 4.59(3)
C-9 -0.4654(2) 0.9187(1) 0.8368(1) 4.77(3)
C-10 -0.3871(2) 0.8494(1) 0.7588(1) 3.62(2)
C-l 1 -0.0640(2) 1.1091(1) 0.89462(8) 3.29(2)
C-12 0.0949(2) 1.0548(1) 0.93343(9) 3.54(2)
C-13 -0.0961(2) 1.2180(1) 0.9046(1) 4.38(3)
C-14 -0.4460(3) 0.8583(2) 0.6717(1) 5.79(4)
C-15 0.1812(2) 0.6811(1) 0.8619(1) 4.12(3)
° Beq — (8 7t^/3)Zi£jUijai aj ai*aj.
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Table 4.5. Coordinates and Equivalent Isotropic Thermal Parameters for 4.4a
atom X V r Bea (A*)0
0-1A 0.2190(6) 0.4585(3) 0.6081(1) 4.90(9)
0-2A 0.2238(8) 0.3525(3) 0.6657(2) 7.6(1)
0-3 A 0.3605(8) 0.6486(3) 0.5576(2) 6-7(1)
0-4A 0.3271(9) 0.5685(3) 0.3922(2) 7.1(1)
C-l A 0.094(1) 0.5504(3) 0.4695(2) 4.6(1)
C-2A 0.052(1) 0.6452(4) 0.4611(3) 6.9(2)
C-3A 0.030(1) 0.6832(4) 0.51-55(3) 6.8(2)
C-4A 0.155(1) 0.6263(4) 0.5512(2) 5.6(2)
C-5A 0.1081(9) 0.5395(3) 0.5322(2) 4.0(1)
C-6A 0.2498(9) 0.4712(3) 0.5502(2) 3.8(1)
C-7A 0.2090(9) 0.3858(3) 0.5241(2) 4.1(1)
C-8A 0.3402(9) 0.3713(4) 0.4751(2) 4.5(1)
C-9A 0.278(1) 0.4257(4) 0.4279(2) 5.5(2)
C-lOA 0.271(1) 0.5183(4) 0.4392(2) 4.5(1)
C-l 1A 0.2355(9) 0.3269(4) 0.5693(3) 4.9(1)
C-12A 0.2267(9) 0.3743(4) 0.6191(2) 5.3(1)
C-13A 0.265(1) 0.2452(4) 0.5686(3) 7.2(2)
C-14A 0.459(1) 0.5651(5) 0.4375(3) 7.0(2)
C-l 5 A 0.229(1) 0.6496(4) 0.6047(3) 6.6(2)
0-1B 0.7720(7) 0.5216(3) 0.1331(1) 5.26(9)
0-2B 0.7719(8) 0.6165(4) 0.0675(2) 7.8(1)
0-3 B 0.9224(9) 0.3467(3) 0.1984(2) 7.8(1)
0-4B 0.838(1) 0.4558(4) 0.3558(2) 8.9(2)
C-1B 0.621(1) 0.4560(4) 0.2752(2) 5.6(2)
C-2B 0.595(2) 0.3635(5) 0.2893(3) 9.5(3)
C-3B 0.591(1) 0.3129(5) 0.2402(3) 8.5(2)
C-4B 0.713(1) 0.3648(4) 0.2018(2) 6.2(2)
C-5B 0.6541(9) 0.4543(4) 0.2123(2) 4.4(1)
C-6B 0.7904(9) 0.5206(4) 0.1919(2) 4.2(1)
C-7B 0.7388(9) 0.6105(4) 0.2097(2) 4.3(1)
C-8B 0.855(1) 0.6368(4) 0.2599(3) 5.8(2)
C-9B 0.785(1) 0.5910(5) 0.3107(3) 6.9(2)
C-l OB 0.787(1) 0.4988(5) 0.3064(2) 5-6(2)
C-l IB 0.7772(9) 0.6588(4) 0.1601(3) 4.9(1)
C-12B 0.7745(9) 0.6023(4) 0.1156(2) 5-5(1)
C-13B 0.813(1) 0.7399(5) 0.1558(4) 8.7(2)
C-14B 0.983(1) 0.4563(7) 0.3123(3) 8.6(2)
C-15B 0.794(2) 0.3340(5) 0.1524(3) 8.3(2)
a Beq — (8 7r,-/3)!£jZjUjjaj aj &i*aj
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Table 4.6. Coordinates and Equivalent Isotropic Thermal Parameters for 4.4c
atom X V - B«(A  zr
01 0.5714(2) 0.7098(1) 0.39907(9) 4.80(3)
02 0.7116(2) 0.8958(2) 0.3942(1) 7.04(4)
03 0.5560(2) 0.3325(2) 0.3468(1) 8.42(4)
04 -0.0431(2) 0.5139(2) 0.2787(1) 9.48(5)
Cl 0.2248(3) 0.4807(2) 0.3402(1) 5.54(5)
C2 0.2003(3) 0.3974(3) 0.4198(2) 7.53(6)
C3 0.3615(3) 0.3791(2) 0.4603(2) 6.49(6)
C4 0.4800(3) 0.4308(2) 0.3980(2) 5.58(5)
C5 0.3959(2) 0.5394(2) 0.3495(1) 4.35(4)
C6 0.4015(2) 0.6694(2) 0.3953(1) 3.75(3)
C l 0.3146(2) 0.7833(2) 0.3526(1) 4.07(3)
C8 0.1412(3) 0.8038(2) 0.3835(2) 5.25(4)
C9 0.0429(3) 0.6768(3) 0.3853(2) ' 6.40(6)
CIO 0.0917(3) 0.5773(2) 0.3197(2) 5.99(5)
C ll 0.4261(3) 0.8959(2) 0.3666(1) 4.46(4)
C12 0.5842(2) 0.8408(2) 0.3868(1) 4.86(4)
C13 0.3982(3) 1.0239(2) 0.3637(2) 6.55(6)
C14 0.0568(3) 0.6065(4) 0.2316(2) 8.23(8)
C15 0.6526(4) 0.4132(3) 0.4015(2) 8.58(7)
a Beq — (8 7r^/3)Xj£jUjjaj aj aj*aj
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a Lactones 4.1a and 4.6 were also tested against M. avium and gave 
MICs of 16 and 128 pg/ml, respectively.
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0
4.1a R = R' = H
O
4.2
4.1b R = OH; R' = H 
4.1c R = H; R' = OH
O
4.4a R[ = a-epoxide; R2 = P-epoxide
O
4.3a R = P-epoxide
4.3b R = a-epoxide 4-4b Ri = a-epoxide; R2 = a-epoxide







Figure 4.1. Dehydrocostus lactone and derivatives























































































































































































































































































Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
106









































































































































































































































































■ -C L  X  





























Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
I l l
Coll, J. C.; Bowden, B. F. J. Nat. Prod. 1986,49, 934.
Connell, N. D.; Nikaido, H. In Tuberculosis: Pathogenesis, Protection, and Control, 
Bloom, B. R., Ed.; ASM Press: Washington D. C., 1994; pp 333-352.
Fronczek, F. R.; Vargas, D.; Fischer, N. H.; Hostettmann, K. J. Nat. Prod. 1984, 47,
1036.
Fronczek, F. R.; Vargas, D.; Parodi, F. J.; Fischer, N. H. Acta. Cryst. 1989, C45, 1829.
Inderleid, C. B.; Nash, K. A. In Antibiotics in Laboratory Medicine-, Lorian, V., Ed.; 
Williams and Wilkins: Baltimore, 1996; pp 127-175.
Inderleid, C. B.; Sal finger, M. In Manual o f  Clinical Microbiology, Murray, P. R., Baron, 
E. J., Pfaller, M. A., Tenover, F. C., and Yolken, R. H., Eds.; ASM Press:
Washington D. C., 1995; pp 1385-1404.
Kalsi, P. S.; Kaur, P.; Chhabra, B. R. Phytochemistry 1979,18, 1877.
Kalsi, P. S.; Kaur, G.; Sharma, S.; Talwar, K. K. Phytochemistry 1984, 23, 2855.
Kalsi, P. S.; Sharma, S.; Kaur, G. Phytochemistry 1983,2 2 ,1993.
Korp, J. D.; Bernal, I.; Fischer, N. H.; Leonard, C.; Lee, I. Y.; LeVan, N. J. Heterocvclic 
Chem. 1982,19, 181.
Lu, T.; Fischer, N. H. Spectroscopy Lett. 1996,29,437.
Romanuk, M.; Herout, V.; Sorm, F. Coll. Czech. Chem. Commun. 1956, 21, 894.
Sepkowitz, K. A.; Raffalli, J.; Riley, L.; Kiehn, T. E.; Armstrong, D. Clinical Microbiol. 
Rev. 1995,8, 180.
Siddiqi, S. H. In Clinical Microbiology Procedures Handbook, Isenberg, H. D., Ed.; 
American Society for Microbiology: Washington, D. C., 1992; pp 5.14.2-5.14.25.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 5
ANTIMYCOBACTERIAL SESQUITERPENE LACTONES FROM INULA 
HELENIUM AND RUDBECKIA SUBTOMENTOSA
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5.1 Introduction
In continuation of our search for new structural types of antimycobacterial natural 
products, active root extracts of Inula helenium and Rudbeckia subtomentosa (Cantrell et 
al., 1998) were chemically investigated. Native Americans (Iroquois, Cherokees, and 
Mohegans) used infusions and decoctions o f  I. helenium roots for the treatment of lung 
disorders and against TB (Moerman, 1986). The crude dichloromethane extract of roots 
of /. helenium gave 100 percent inhibition against M  tuberculosis at 100 ng/ml. 
Therefore, a detailed chemical investigation of its active fractions was performed. Since 
a bioassay-guided fractionation of the crude extract of R  subtomentosa had also 
demonstrated a 99 percent inhibition against M  tuberculosis at 100 pg/ml, the active 
fractions were also chemically investigated for their constituents. The chemical studies 
and their biological activities will be discussed below.
5.2 Results and Discussion
The results of radiorespiratory antituberculosis bioassays of crude extracts of /. 
helenium and R. subtomentosa, using solvents of increasing polarity, are presented in 
Table 5.1. The hexane and dichloromethane extracts of /. helenium roots demonstrated 
100 percent inhibition at 100 pg/ml.
VLC chromatography of the dichloromethane root extract of I. helenium and 
subsequent bioassay of the fractions against M. tuberculosis indicated that the nonpolar 
fractions 2, 3, and 4 contain the biologically active constituents responsible for the high 
active of the crude extract (Table 5.2). All three fractions gave 99 percent inhibitions at 
33 pg/ml against M  tuberculosis. Chemical investigation of these fractions resulted in 
the isolation of the known eudesmanolides, alantolactone (5.1), isoalantolactone (5.2a),
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and 11, 13-dihydroisoalantolactone (53), as shown by spectroscopic comparison with 
data previously reported for these three sesquiterpene lactones (Kashman et al., 1967; 
Bohlmann et al., 1978; Milman, 1990; Marshal et al., 1964).
Bioassay of crude extracts of various plant parts of R. subtomentosa indicated that 
root extracts were most active against M. tuberculosis with a 99 percent inhibition at 100 
Hg/ml. VLC fractionation results of the root extract of R. subtomentosa are summarized 
in Table 5.2. Further VLC separation o f the most active fractions 2 and 3 provided the 
known alloalantolactone (53a) and fraction 4 afforded the known 3-oxoalloalantolactone 
(5.5b) as the major component and 5.5a as a minor constituent. Both compounds 5.5a 
and 5.5b had been previously isolated from Eupatorium quadrangularae (Okunade et al., 
1985), but this is the first report of their isolation from R. subtomentosa. The structures 
of 5.5a and 5.5b were determined by spectral comparison with previously reported data 
(Bohlmann et al., 1978; Okunade et al., 1985).
The eudesmanoiides isolated from /. helenium and R. subtomentosa were tested 
for their biological activities against M. tuberculosis. Lactones 5.1, 5.2a, and 5.5a had 
MICs of 32 pg/ml while compounds 5 3  and 5.5b showed MICs of >128 pg/ml and 128 
pg/ml, respectively (Table 5.4). Various eudesmanoiides of structures similar to those 
isolated from /. helenium and R. subtomentosa were also evaluated for their in vitro 
activities against M. tuberculosis. Encelin (5.2b) was the most active with an MIC of 16 
pg/ml and l,2-dehydro-3-epi-isotelekin (53c) and isoalloalantolactone (5.4) showed 
values of 32 jig/ml and 128 ng/ml, respectively (Table 5.4).
Therefore, a preliminary evaluation of structure activity relationships within this 
series of biologically active compounds suggested that epoxidation of the C-5 double
permission of the copyright owner. Further reproduction prohibited without permission.
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bond of 5.1 or the C-4(14) double bond of 5.2a may result in derivatives with lower 
MICs. In our previous study of cycloartane-type triterpenes from Borrichm fruiescens 
(Cantrell et al., 1996), epoxides were more active against M. tuberculosis than their 
corresponding alkene analogs.
Epoxidation of 5.2a provided epoxide 5.6, which had been previously isolated 
(Jakupovic et al., 1988) and synthesized (Chen et al., 1994). Its structure was determined 
by spectral comparison, mainly of lH NMR values with those previously reported 
(Jakupovic et al., 1988) and was shown to be identical in all respects.
Epoxidation of 5.1 gave epoxide 5.7, which was identified by 'H, 13C NMR, 
including 90° and 135° DEPT methods and mass spectroscopy as well as comparison of 
spectroscopic data with values previously reported for similar lactones (Bohlmann et al., 
1978; Marshal et al., 1964). The molecular structure of 5.7 was confirmed by single 
crystal X-ray crystallography.
In an attempt to synthesize a 5,6-diol derivative, lactone 5.1 was reacted with 
0 s04 Dihydroxylation occurred exclusively at the lactonic 11,13-double bond to provide 
diol 5.8 which gave a MS parent peak at m z  266. The *H NMR spectrum indicated that 
the H-6 doublet of 5.1 (8 5.11) was nearly unchanged in 5.8 (8 5.03, d) enabling us to 
suggest that dihydroxylation had occurred at the 11,13- rather than at the 5,6- position. 
Instead, the two diagnostic methylene lactone signals (H-13) were missing in 5.8. 'H 
NMR values are reported in Table 5.3 and peak assignment of diol 5.8 were made by 
spectroscopic comparison with data of structural analogs (Kashman et al., 1967; 
Bohlmann et al., 1978; Milman, 1990; Marshal et al., 1964).
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Oxidative modifications by epoxidation of 5.1 produced a-epoxyalantolactone 
(5.7), with a MIC of 8 pg/ml, a value significantly lower than observed for 5.1 with an 
MIC of 32 pg/ml. In contrast, epoxide 5.6 gave an MIC of 32 pg/ml which is the same 
value as that of its starting molecule (5.2a). This suggests that the 4(15) double bond in 
5.2a may be less important for biological activity, which could only be confirmed with 
further modifications. Oxidation of compound 5.1 to diol 5.8 resulted in complete loss of 
biological activity. Compound 5.8 gave a MIC of >128 pg/ml in contrast to the MIC of
5.1 of 32 pg/ml. This strongly supports the necessity of the presence of the a , (3- 
unsaturated lactone group, which is quite likely acting as a site of alkylation. Further 
support for the necessity of the lactonic double bond is seen when observing the high 
activity of compound 5.2a (32 pg/ml) as compared to the inactivity of its 11(13) 
dihydroderivative 5 3  (>128 pg/ml).
5.3 Experimental
General Experimental Procedures. 'H- and l3C-NMR spectra were recorded in 
CDCI3 on a Bruker ARX 300 MHz spectrometer. Mass spectra were obtained on a 
Hewlett-Packard 5971A GC-MS instrument. IR spectra were run on a Perkin-Elmer 
1760X spectrometer as a film on KBr plates. Vacuum-liquid chromatographic (VLC) 
separations were carried out on silica gel (MN Kieselgel) (Coll et al., 1986).
Plant material. Roots of I. helenium were collected on June 25, 1995 and 
obtained from Mr. George Sturtz of Aromagen, 31787 Peoria Road, Albany, Oregon 
97321, U.S.A.. A voucher (Sturtz-Fischer number 570) is deposited at the Louisiana 
State University Herbarium. The crude plant extract of R. subtomentosa was obtained 
from our repository, which we had previously chemically investigated (Vasquez et al,
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1990). The voucher is deposited at the Herbarium o f Louisiana State University, U.S.A.. 
Cox No 4923.
Extraction and isolation. Root material (4.5 kg) of I. helenium was cut into 
small pieces and dried at room temperature for two weeks. After soaking in hexane for 
24 hours the solvent was drained from the plant residue and evaporated in vacuo to yield 
15.16 g of crude extract. The remaining plant material was re-soaked for 24 hours in 
CHiCL and subsequently for 24 hours in MeOH, yielding 23.3 g and 85.2 g, respectively. 
The CH2CI2 extract was absorbed onto silica gel (15.2 g) and separated by VLC (Coll et 
al., 1986) into 11 fractions using solvents of increasing polarity (hexane, ethyl acetate, 
and MeOH) as summarized in Table 5.2. The most active fractions 2-4 were further 
separated by repeated VLC over silica gel, essentially as described previously, to yield 
pure compounds 5.1 ,5.2a, and S3  (Kashman et al., 1967; Bohlmann et al., 1978).
Previously obtained CH2CI2 root extract (1.75 g) o f  R. subtomentosa (Vasquez et 
al., 1990) was adsorbed onto 1.6 g silica gel and placed onto a 2.3 cm i. d. VLC column 
packed with 25 g of silica gel. The extract was separated into 8 fractions o f increasing 
polarity using hexane, EtOAc, and MeOH or mixtures thereof as listed in Table 5.2. The 
most active fraction 2 (120 mg) was adsorbed onto 200 mg o f silica gel and placed onto a
1.3 cm i. d. VLC column containing 5 g of silica gel. Subsequent elution using 10 ml 
fractions of hexane:EtOAc of increasing polarity afforded 17 mg of alloalantolactone 
(5.5a). Fraction 3 (88 mg) was separated as described above for fraction 2 to afford 7 mg 
of compound 5.5a. Fraction 4 (167 mg) was adsorbed onto 240 mg of silica gel and 
placed onto a 1.3 cm i. d. VLC column that was packed with 6 g of silica gel. Elution of
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the column with 20 ml fractions of hexane:EtOAc of increasing polarity afforded 19 mg 
of pure 5.5b.
Radiorespirometric Bioassays. Bioassays were performed essentially as 
described previously (Cantrell et al., 1996; Inderleid et al., 1996; Inderleid et al., 1995; 
Siddiqi et al., 1992). Experiments for M  tuberculosis were usually completed within ten 
days.
Epoxidations of 5.1. Lactone 5.1 (101 mg) was dissolved in 10 ml of CLLCL 
and added to a solution of 10 ml of CH2CI2 containing 1.2 equivalents mCPBA. Reaction 
mixture was kept in an ice bath and stirred until TLC indicated all o f 5.1 had reacted. 
Reaction was stopped at 1.5 hours and washed with 10 ml of 10 % aqueous NaHCC>3 and 
subsequently with 10 ml H2O. Organic phase was dried with anhydrous MgS04 and 
crude reaction products were separated by prep TLC (Si0 2 ) using hexane/EtOAc (5:2) as 
the mobile phase to yield 103 mg of 5.7. Lactone 5.2a was converted to epoxide 5.6 
essentially as described previously (Jakupovic et al., 1988).
5 ,6a-Epoxyalantolactone (5.7). C 15H20O3 (Mr! 248) colorless crystals in
EtOAc; m. p. 164-166 °C; IR u max (KBr), 1741 (C=0) cm-1; EI-MS (70 eV): m = (% 
rel. int.) = 248 (M+, 9), 233 (Nf-Me, 7), 204 (14), 192 (6 ), 159 (6 ), 149 (28), 133 (11), 
126 (30), 123 (34), 109 (86), 95 (44), 81 (100), 67 (74), 55 (73); 'H-NMR and 13C-NMR 
see Table 5.3.
Os04 oxidation of 5.1. To an ice-cooled solution of 134.9 mg o f a 50 % solution 
of 4-methylmorpholine //-oxide in water was added a solution of 0.33 mg Os04 dissolved 
in 0.33 ml r-BuOH. Lactone 5.1 (125.7 mg) dissolved in 3 ml of acetone was added and 
the reaction mixture stirred for 18 hours (Renound-Grappin et al., 1994). A solution of
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aqueous 10 % NaHSOj (3 ml) was added and all solvents evaporated on rotary 
evaporator. Crude mixture was absorbed onto silica gel and separated by VLC (2.3 cm i. 
d. column) to provide fractions of increasing polarity using hexane and hexane:EtOAc 
mixtures resulting in pure 5.8 (102 mg).
11, 13-Dihydroxyalantolactone (5.8). CisH^rOi (Mr: 266) colorless oil; ER u 
max (KBr), 3388 (OH) cm*1; EI-MS (70 eV): m : ( %  rel. int.) = 266 (M+, 16), 251 (NT- 
Me, 1), 235 (10), 221 (6), 215 (19), 207 (3), 191 (12), 162 (100), 147 (33), 133 (15), 119 
(25), 105 (96), 91 (89), 77 (30), 67 (18), 55 (37); 1 H-NMR and I3C-NMR see Table 5.3.
Compounds 5.2b, 5.2c, and 5.4. Other sesquiterpene lactones used for bioassays 
had been previously isolated in our laboratory. Isoalloalantolactone (5.4) had been 
obtained from Rudbeckia mollis (Vasquez et al., 1992). Encelin (5.2b) and 1,2-dehydro-
3-epi-isotelekin (5.2c) (Geissman et al., 1968) were provided by Professor Leovigildo 
Quijano, UNAM, Mexico City.
X-ray Crystallographic analysis of epoxide 5.7. A colorless fragment of 
dimensions 0.62x0.35x0.35mm was used for data collection at T=100K on an Enraf- 
Nonius CAD4 diffractometer equipped with MoKa radiation (>.=0.71073 A) and a 
graphite monochromator. The temperature of the sample was maintained by an Oxford 
Cryostream device. Crystal data are: C)5H20O3) Mr=248.3, monoclinic space group
P2i, a=7.968(6), b=6.181(2), c=13.132(4) A, 0= 105.58(6)°, V=623.0(8) A3, Z=2, 
dc=1.324 g cm-3. Intensity data were measured by co-20 scans of variable rate. Two
quadrants of data were collected within the limits 2<9<30°. Data reduction included 
corrections for background, Lorentz, and polarization effects. 3938 intensities were 
averaged to yield 1974 unique data (Rint=0.019), of which 1932 had I>0 and were used
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in the refinement. The structure was solved by direct methods using SER92 (Altomare et 
al., 1994) and refined by fiill-matrix least squares, treating nonhydrogen atoms 
anisotropically. Hydrogen atoms were located in difference maps and refined 
isotropically. Convergence was achieved with R=0.031, Rw=0036, and GOF= 1.687. 
The Enraf-Nonius MolEN programs (Fair, 1990) were used for all computations. The 
structure is illustrated in Figure 5.1, and fractional coordinates are given in Table 5.5.
Table 5.1. Percent Inhibition of Crude Plant Extracts of Inula helenium and Rudbeckia 
subtomentosa Against Mycobacterium tuberculosis at 1000 and 100 pg/ml
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flowers D 95 30
* H=hexane; D=dichloromethane; Vl=methanol
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Table 5.2. Percent Inhibition of Inula helenium and Rudbeckia subtomentosa Fractions 
Against M. tuberculosis
fraction solvent percentages / helenium R. subtomentosa
(Hexane:EtOAc:MeOH)
I. heleniuma R. subtomentosa b 100 33 100  ̂->
pg/ml Hg/ml Hg/ml lig/ml
1 100:0:0 100:0:0 100 94 79 43
2 95:5:0 95:5:0 100 99 100 97
«■*
J 90:10:0 75:25:0 100 99 99 91
4 85:15:0 50:50:0 99 99 99 67
5 80:20:0 25:75:0 99 96 53 26
6 70:30:0 0:100:0 92 84 26 24
7 50:50:0 0:50:50 90 80 28 23
8 0:100:0 0:0:100 -20 -9 70 44
9 0:50:50 - -14 -10
10 0:50:50 - -3 10 _ -
11 0:0:100 - -19 -12 - -
a Using 6.5 cm i.d. column with 200 ml of solvent for each fraction. 
b Using 2.3 cm i.d. column with 100 ml of solvent for each fraction.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
122
ii
Table 5.3. 'H NMR (300 MHz) and !3C NMR (75.4 MHz) Spectral Data of Compounds 
5.7 and 5.8 (CDC13) a
atom 1 5.7 ! 5.8
‘H NMR I3c n m r ‘H NMR I 13c n m r
1 37.71* 42.3 t*
2 16.5 t - 16.9 t
3a . 29.5 t 1.54 m 32.9 t
3p - - 1.54 m -
4 1.34 m 37.1 d** 2.47 m 38.6 d
5 - 67.5 s - 152.9 s
6P 2.89 d (2.6) 61.2 d 5.03 d (3.5) 112.5 d
7a 3.66 dddd (2.5, 
2.6, 2.9, 8.8)
37.4 d** 2.98 dd (3.5, 
5.6)
44.9 d
8a 4.66 ddd (1.9, 
4.5, 8.8)
75.2 d 5.12 ddd (3.0. 
3.0, 5.6)
78.0 d
9a 1.55 dd (1.9, 
15.0)
39.6 t * 1.54 dd (3.0, 
15.0)
42.6 t*
9P 1.87 dd (4.5, 
15.0)
- 2.14 dd (3.0, 
15.0)
-
10 - 32.6 s - 33.0 s
11 - 136.7 s - 77.4 s
12 - 169.7 s - 177.9 s
13a 5.77 d (2.5) 123.8 t 3.72 br d 
(12.0)
64.2 t
13b 6.39 d (2.9) - 3.93 d (12.0) -
14 1.10s 24.0 q 1.22 s 28.8 q
15 1.03 d (2.7) 18.1 q 1.12 d (7.6) 23.1 q
11-OH - - 3.77 b rs -
13-OH - 2.93 br d (9.9) -
a Expressed as 8 values in ppm, with J  values in Hz in parentheses. 
* Data in same column are interchangeable.
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Table 5.5. Coordinates and Equivalent Isotropic Thermal Parameters for 5.7 a
atom .r iy - Bq q(A-)
01 0.2578(1) 0 0.52446(7) 1.32(2)
02 0.1467(1) -0.3326(2) 0.49271(7) 1.59(2)
03 0.4076(1) 0.2927(2) 0.83350(7) 1.35(2)
Cl 0.7548(2) 0.2840(3) 0.75276(9) 1.22(2)
C2 0.8863(2) 0.1986(3) 0.8518(1) 1.39(2)
C3 0.8052(2) 0.1817(3) 0.9450(1) 1.40(2)
C4 0.6416(2) 0.0379(3) 0.91.896(9) 1-16(2)
C5 0.5173(2) 0.1137(2) 0.81574(9) 1.02(2)
C6 0.3296(2) 0.0850(2) 0.79999(9) 1-14(2)
C7 0.2001(2) 0.0807(2) 0.69209(9) 1.12(2)
C8 0.2689(2) 0.1766(3) 0.60147(9) 116(2)
C9 0.4526(2) 0.2687(2) 0.63338(9) 1.19(2)
CIO 0.5876(2) 0.1449(2) 0.71898(9) 0.98(2)
C ll 0.1473(2) -0.1459(2) 0.6558(1) 1.15(2)
C12 0.1798(2) -0.1769(3) 0.5500(1) 1.21(2)
C13 0.0856(2) -0.3044(3) 0.7032(1) 1.78(3)
C14 0.6279(2) -0.0748(3) 0.67540(9) 1.20(2)
C15 0.6857(2) -0.2046(3) 0.9212(1) 1.45(2)
Hla 0.806(2) 0.287(3) 0.692(1) 1-1(3)*
Hlb 0.720(2) 0.423(3) 0.768(1) 1-5(3)*
H2a 0.989(2) 0.297(3) 0.869(1) 2.3(4)*
H2b 0.936(2) 0.058(3) 0.838(1) 1.8(4)*
H3a 0.777(2) 0.329(4) 0.964(1) 2.7(4)*
H3b 0.896(2) 0.131(3) 1.008(1) 1-6(3)*
H4 0.580(2) 0.061(3) 0.973(1) 0.6(3)*
H6 0.290(2) 0.017(3) 0.853(1) 1.3(3)*
H7 0.097(2) 0.157(3) 0.694(1) 1.3(3)*
H8 0.184(2) 0.291(3) 0.562(1) 1.4(3)*
H9a 0.442(2) 0.416(3) 0.659(1) 1.5(3)*
H9b 0.495(2) 0.271(3) 0.570(1) 1.3(3)*
H13a 0.051(2) -0.440(3) 0.665(1) 2.2(4)*
H13b 0.060(2) -0.284(4) 0.772(1) 2.1(4)*
H14a 0.643(2) -0.056(4) 0.604(1) 1.9(4)*
H14b 0.529(2) -0.174(3) 0.667(1) 1.4(3)*
H14c 0.730(2) -0.139(3) 0.722(1) 1.3(3)*
HI 5a 0.775(2) -0.231(3) 0.886(1) 1.4(3)*
HI 5b 0.578(2) -0.278(3) 0.887(1) 1.7(4)*
HI 5c 0.732(2) -0.250(3) 0.993(1) 2.2(4)*
a Figures in parentheses are ESD.





5.5a R = H 
5.5b R = 0=
:0
R
5.2a R = H
5.2b R = 0=, A 1, 2-d.b. 




c h 2o h
5.8
Figure 5.1 Sesquiterpene lactones isolated from I. helenium and R. subtomentosa
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6.1 Introduction
Melia volkensii Gurke (Meliaceae) is a subtropical tree which is found in dry 
areas of East Africa. It has been reported that a tea prepared from the bark is used in 
local folk medicine to alleviate pain and is poisonous in overdose (Kokwaro, 1976). It 
has recently been shown that an extract of the seed kernels possess potent antifeedent 
activity against the desert locust, Schistocerca gregaria (Nasseh et al., 1993; Mwangi, 
1982). Fruit kernel extracts have also demonstrated growth-inhibiting activity against 
larvae of the mosquitoes Aedes aegypti and Anopheles arabiensis (Mwangi et al., 1988a; 
Mwangi et al., 1988b). Chemical investigations o f the fruits have resulted in the 
isolation of the insect antifeedants volkensin, salannin, 1-cinnamoyltrichilinin, 1- 
tigloyltrichilinin, and 1-acetyltrichilinin (Rajab et al., 1988a; Rajab et al., 1988b). More 
recent investigations of M  volkensii have focused on the investigation leading to 
compounds with activity against the human breast tumor cell line (MCF-7). These 
chemical investigations resulted in the isolation of meliavolin, meliavolkin, meliavolen, 
melianinone, 3-episapelin A, nimbolin B, meliavolkensins A and B, melianin A. and 
meliavolkenin (Zeng et al., 1995a; Zeng et al., 1995b; Zeng et al., 1995c; Zeng et al., 
1995d).
Described below is the chemical investigation of the methanol extract of the 
seeds of M  volkensii, which resulted in the isolation of two new and one previously 
isolated triterpenes. Their structure elucidation and spectroscopic characterization as 
well as results of bioassays against Mycobacterium tuberculosis are presented.
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6.2 Results and Discussion
In a screening of crude plant extracts for biological activity against M  
tuberculosis (Cantrell et al., 1998), the methanol extract of the seeds of Melia volkensii 
was chosen for investigation because it demonstrated 99 percent inhibition against M  
tuberculosis at 100 pg/ml. From this crude extract, the known kulonate (6.2) and the 
new 12 [5-hydroxy kulac tone (6.1a) and 6 (5-hydroxy kulactone (6.1b) were isolated. 
Kulonate (6.2) had been previously isolated from Melia azedarach (Chiang et al., 1973). 
Compounds 6.1a and 6.1b are hydroxyl derivatives of kulactone (6.1c), which had also 
been previously isolated from M. azedarach (Chiang et al., 1973; Ochi et al., 1977).
The crude methanol extract of the seeds of M. volkensii was fractionated using 
vacuum liquid chromatography (VLC) into 10 fractions of increasing polarity as 
indicated in Table 6.1. Each fraction was subsequently tested for its biological activity 
against M. tuberculosis at 100 pg/ml and 33 pg/ml as summarised in Table 6.1. 
Fractions 3, 4, and 5 were most active with percent inhibitions of 82, 96, and 95 at 33 
pg/ml, respectively. This suggested that the active principles responsible for the high 
inhibition of this crude extract are likely to be present in these three fractions. 
Consequently, chemical investigation began with the most active fraction 4.
Multiple vacuum liquid chromatographic (VLC) investigations of fraction 4 (refer 
to Experimental) resulted in the isolation of compound 6 . 1 a, 6.1b, and 6.2. The IR data 
for 6.1a indicated the presence o f hydroxyl(s) (3516 cm'1) and carbonyls (1781 cm'1, 
1705 cm'1), the peak at 1781 cm'1 strongly suggesting the presence of a y-Iactone moiety. 
FAB mass spectral data indicated a parent molecular ion at m z  469.2 corresponding to 
[M+H]+. Inspection of the lH NMR spectral data (Table 6.2) for 6.1a indicated the
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presence of seven methyl singlets, two one-proton olefinic signals at 8 5.39 and 8  5.11, 
and two deshielded one-proton signals at 8  4.19 and 5 4.03. The 'H-NMR data combined 
with IR and mass spectral data suggested that 6.1a is structurally closely related to and is 
most likely a hydroxylated derivative of kulactone (6.1c), a compound which had been 
previously isolated from M  azedarach (Chiang et al., 1973; Ochi et al., 1977). This was 
supported by the presence of a proton absorption at 8 4.03 (dd, 7=4.6, 9.3) in 6.1a 
corresponding to H-12, which was the only proton absorption not present in the spectrum 
of 6.1c.
The 13C-NMR experiments confirmed the presence o f seven methyls, and 
indicated that ketone (5 216.3 s), lactone (8 180.6 s. 8 82.3 d), and hydroxyl (8  72.2 d) 
groups must be present. I3C-NMR assignments were based on DEPT, HMQC, and 
HMBC spectral data (Tables 6.2 and 6.3). The location of the hydroxyl group was 
assigned by HMBC experiments (Table 6.2), which indicated the presence o f  a long 
range (3J) coupling between C-12 and H-18 in the HMBC experiment (Figure 6 .1). 
Additional spectral assignments and HMBC couplings are listed in Table 6.2 and are 
summarized by arrows in Figure 6.1. An NOE correlation between H-12 and H-18 
suggested that by analogy with 6.1c, the relative configuration of the hydroxyl group at 
C-12 had to be p.
Further investigations of fraction 4 resulted in the isolation o f compound 6.1b 
(C30H44O4), which gave a parent peak of me 469.5 in the FABMS corresponding to 
[M+H]+. IR spectral data indicated that all absorptions were very similar to those 
observed for 6.1a with a  hydroxyl absorption at 3504 cm '1. ‘H-NMR chemical shifts and 
splitting patterns of 6.1b (Table 6.2) were very similar to those of 6.1a. However, instead
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of the resonance corresponding to H-12 (5 4.03 dd) in 6.1a a farther down field broad 
singlet appeared at 8 4.49 in 6.1b. Examination of the COSY spectrum of 6.1b indicated 
a strong coupling between the olefinic proton H-7 and the broad singlet at 5 4.49 which 
suggested that 6.1a and 6.1b are constitutional isomers differing only in the position of 
the hydroxyl group, which must be at C-6 in 6.1b. In addition to the COSY couplings 
shown above, examination of HMQC and HMBC spectral data for 6.1b (Table 6.2) 
confirmed that the hydroxyl group was located on C-6 due to a strong coupling between 
H-5 (8 1.49 d) and C-6 (8 67.3), which had to be an oxygen-bearing carbon based on 
chemical shift considerations. A strong coupling observed between H-6 and H-29 in the 
NOESY spectrum revealed that the relative configuration of the OH group at C-6 had to 
be |3. All ‘H-NMR and I3C-NMR spectral peak assignments were based on DEPT, 
HMQC, and HMBC experiments and the data is summarised in Table 6.2 and Table 6.3, 
respectively. A summary of HMBC correlations of 6.1b is presented in Figure 6.1.
Also isolated from fraction 4 was kulonate (6.2), which had been previously 
obtained from M azedarach (Chiang et al., 1973) and represents the methyl ester 
solvolysis product of kulactone (6.1c). Identification of 6.2 was done by comparison of 
spectroscopic data (IR, lH-NMR, and l3C-NMR) with previously reported values (Chiang 
et al., 1973).
All compounds isolated from M  volkensii were evaluated for biological activity 
against M. tuberculosis (H37Rv) using a radiorespirometric bioassay (Cantrell et al., 
1996; Inderleid et al., 1996; Inderleid et al., 1995; Siddiqi et al., 1992). Triterpenes 6.1a 
and 6.2 showed MICs o f 16 pg/ml, while 6.1b had an MIC of 4 pg/ml.
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6.3 Experimental
General Experimental Procedures. Mass spectra were obtained on a Hewlett- 
Packard 5971A GC-MS or a TSQ70 FAB mass spectrometer. IR spectra were run on a 
Perkin-Elmer 1760X spectrometer as a film on KBr plates. Vacuum-liquid 
chromatographic (VLC) separations were carried out on TLC grade silica gel (MN 
Kieselgel) (Coll et al., 1986). lH- and l3C-NMR spectra were recorded in CDC1? on 
either a Bruker AM 400 MHz spectrometer or a Bruker ARX 300 MHz spectrometer. 2D 
NMR were recorded using a Bruker ARX 300 MHz spectrometer utilising Bruker’s 
standard pulse programs. In the Heteronuclear Multiple Bond Correlation (HMBC) 
experiments (Bax et al., 1986) the following parameters were used: relaxation delay of 1 
s, 60 ms delay for evolution of long-range couplings, coupling constant of 145 Hz. In the 
Heteronuclear Multiple Quantum Coherence (HMQC) experiments (Bax et al., 1983) a 
relaxation delay of 1 s was used with a coupling constant of 145 Hz. In the NOESY 
experiments, a relaxation delay of 2 s was used with a mixing time of 0.8 s. In HMBC 
and HMQC experiments, 2048 data points were collected in t2, with 256 FED’s in ti. 
Typical sweep widths were 6 ppm in F2 and 220 ppm in FI. The spectra were 
transformed into a 2048 x 512 matrix by zero filling.
Plant Material. Seeds of M  volkensii were obtained from ripening fruits 
collected in November 1995 in Voi, Kenya. A voucher specimen (Voucher No. 
MU/BOT/75M) has been deposited at the Department of Botany Herbarium, Moi 
University, Kenya.
Extraction and Isolation. Crushed seeds (1 kg) were allowed to stand in 2 L of 
MeOH for 1 week. The extract was decanted and the residual pulp re-extracted under
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similar conditions. The combined extracts were evaporated under vacuum to yield 18.6 g 
of a thick brown oil. Part of the of the crude MeOH extract (8.0 g) was adsorbed onto 8.0 
g of silica gel and packed onto a 6.5 cm i. d. column containing 160.0 g o f silica gel. The 
crude extract was separated into 10 fractions using an increasing polarity gradient of 
hexane, EtOAc, acetone, and methanol as summarized in Table 6.1. After evaluation of 
each fraction for its antimycobacterial activity, the most active fraction 4 was chosen for 
further chromatographic investigation.
Fraction 4 (410 mg) was adsorbed on 360 mg of reverse phase C-l 8 silica gel (40- 
63 pm) and placed onto a VLC column (2.3 cm in diameter) packed with 8.1 g of C-l 8 
silica gel and chromatographed using 20x50 ml H20:MeOH mixtures of decreasing 
polarity. 61 fractions (20 ml each) being collected. Subfractions 46-50 (88 mg) were 
combined as well as subfractions 51-54 (53 mg) due to similar TLC and NMR patterns 
and each were further separated.
The mixture of compounds in subfractions 46-50 were adsorbed onto 112 mg of 
silica gel and placed onto a VLC column (2.3 cm i. d.) packed with 7.5 g o f silica gel and 
chromatographed using 18x50 ml hexanerEtOAc mixtures o f increasing polarity, 58 
fractions (20  ml) being collected. Subfractions 19-22 contained 8 mg o f pure 6.1a and 
fractions 23-27 provided 12 mg of 6.1b.
The mixture of compounds in subfractions 51-54 were separated in a manner 
similar to that described above for subfractions 46-50, providing 69 fractions (20 ml 
each) with fractions 27-29 providing 6 mg of pure 6.2.
12P-hydroxykulactone (6.1a). colorless oil; C30H44O4; mol wt 468; IR u max 
(KBr), 3516 (OH), 2979, 1781 (y-lactone), 1705 (ketone), 1452, 1365 cm-l; 1 H-NMR
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spectral data see Table 6.2; 13C-NMR spectral data see Table 6.3; EIMS (70 eV) m z 444 
(5), 296 (9), 148 (72), 120(28), 107 (100), 91 (17), 77 (11), 65 (6), 55 (6); FABMS m z  
[M -H f 469.2, [469-H20]~ 451.2.
6f3-hydroxykuiactooe (6.1b). colorless oil; C30H44O4; mol wt 468; IR u max 
(KBr), 3504 (OH), 1781 (y-lactone), 1705 (ketone), 1452, 1365 cm '1; 1H-NMR spectral 
data see Table 6.2; 13C-NMR spectral data see Table 6.3; EIMS (70 eV) m z  [M-HiO]^ 
444(11), 393 (4), 227(28), 185 (18), 171 (16), 157(16), 145 (18), 119(18), 107 (28), 91 
(26), 81 (26), 69 (100), 55 (54); FABMS m z [M +H f 469.5, [469-H20 f  451.2.
Radiorespirometric Bioassays. Bioassays were performed essentially as 
described previously (Cantrell et al., 1996; Inderleid et al., 1996; Inderleid et al., 1995; 
Siddiqi et al., 1992) using BACTEC radiorespirometry. Experiments were usually 
completed within 10 days.
Table 6.1. Inhibitory Activity o f Fractions of a Crude Methanol Extract of Fruits of 
Melia volkensii Against Mycobacterium tuberculosis (H3 7 RV)
fraction3 % hexane % EtOAc % acetone % MeOH percent inhibition
100 pg/ml 33 pg/ml
1 100 0 0 0
2 95 5 0 0 - -
j 80 20 0 0 95 82
4 50 50 0 0 97 96
5 20 80 0 0 97 95
6 0 100 0 0 57 0
7 0 50 50 0 0 0
8 0 0 100 0 0 0
9 0 0 50 50 0 0
10 0 0 0 100 0 0
“200 ml of solvent.
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Table 6.2. 'H-NMR (400 MHz, CDCl,) and HMBC (300 MHz, CDC13) Spectral Data of 
Compounds 6.1a and 6.1b
proton 6.1a 6.1b
5h multi, J (Hz)a HMBC 8h multi, J (Hz)a HMBC
1 b 1.97 m - - -
~ P 2.78 ddd 
(5.5, 14.6, 14.6)
1,3 2.86 ddd 
(5.5,14.1, 14.1)
1,3





6 - - 4.49 brs -
7 5.39 brd 
(2.4)
- 5.46 dd 
(3.5, 3.5)
-
12 a 4.03 dd 
(4.6, 9.3)
* - *
15a 1.75 m 13, 14, 16, 30 1.76 dd 
(7.2, 13.6)
13, 14, 16, 30
15b ” - 2.34 dd 
(10.2, 13.6)
-
16 a 4.19 ddd 
(7.3, 10.4, 12.0)
20 4.15 ddd 
(7.2, 10.2, 12.0)
-
17 P 2.53 dd 
(12.0, 12.0)
14, 16, 18,20 2.14 dd 
(12.0, 12.0)
13, 16,18
18 0.83 s 12, 13, 14, 17 0.91 s 12, 13, 14, 17
19 1.04 s 1,5, 9, 10 1.26 s 1,5, 9, 10
23 2.18 m 20, 22, 24, 25 - -
24 5.11 dddd 
(1.1, 1.1, 7.2, 
7.2)
- 5.10 dddd 
(1.3, 1.3, 6.9, 
6.9)
-
26 1.69 s 24, 25, 27 1.69 s 24, 25, 27
27 1.63 s 24, 25, 26 1.62 s 24, 25, 26
28 1.13s 3,4, 5,29 1.52 s 3,4, 5, 29
29 1.05 s 3, 4, 5, 28 1.23 s 3, 4, 5, 28
30 1.39 s 8, 13, 14,15 1.31 s 8, 13, 14, 15
a Expressed as 8 values in ppm, with J  values in Hz in parentheses.
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C-l 38.6 t 40.2 t
C-2 34.91 34.9 t
C-3 216.3 s 216.0 s
C-4 48.1 s 49.2 s
C-5 52.6 d 56.9 d
C-6 24.61 67.3 d
C -l 119.4 d 122.2 d
C-8 143.2 s 146.3 s
C-9 48.2 d 49.0 d
C-10 35.5 s 35.7 s
C-l 1 30.3 t 17.01 *
C-12 72.2 d 29.5 t
C-13 55.2 s *** 39.6 s
C-14 44.9 s *** 55.4 s
C-l 5 36.5 t 35.71
C-16 82.3 d 82.4 d
C-l 7 53.5 d 58.3 d
C-l 8 20.1 q 21.6 q
C-19 12.8 q 15.3 q
C-20 45.7 d 45.6 d
C-21 180.6 s 180.6 s
C-22 29.3 t 29.71*
C-23 26.2 t 26.3 t *
C-24 123.8 d 123.5 d
C-25 133.0 s 133.0 s
C-26 26.0 q * 25.9 q
C-27 18.1 q* 18.1 q
C-28 21.6 q** 24.9 q
C-29 24.6 q ** 24.1 q
C-30 34.0 q 31.6 q
a Peak multiplicities were determined by heteronuclear multipulse programs (DEPT); s = 
singlet, d = doublet, t = triplet, q = quartet. 
b Interchangeable peaks are represented by *, **, or ***.
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6.1a R,=OH; R2=H 





Figure 6.1. Triterpenes isolated from M. volkensii






Figure 6.2. ‘H-I3C HMBC correlations for 6.1a and 6.1b
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Two-hundred and thirty crude extracts from 118 plant species distributed among 
ten families were evaluated for antimycobacterial activity, which was determined against 
Mycobacterium tuberculosis (H37R.V) and M. avium, using the BACTEC 460 
radiorespirometric assay. At 100 Mg/ml, twenty-four and ten of the extracts, respectively, 
caused more than 95% inhibition of growth of M. tuberculosis and M. avium. The most 
active plant extracts with 100% inhibition were obtained from Borrichia frutescens, 
Solidago arguta, and Inula helenium against M. tuberculosis. Euthamia leptocephala 
was active against M. avium, and Erigeron strigosus and Magnolia acuminata were 
active against both mycobacteria. Extracts possessing high biological activities were 
chemically investigated in an effort to isolate the active principles.
The sea daisy (Borrichia frutescens, Asteraceae) collected from coastal marshes 
of Louisiana, was chemically investigated for its active constituents due to the high 
activity of its crude extracts against M. tuberculosis. Bioactive chromatographic 
fractions provided two new triterpenes, (24/?)-24,25-epoxycycloartan-3-one and (23/?)-3- 
oxolanosta-8,24-dien-23-ol, and (24/?)-24,25-epoxvcycloartan-3£-ol, which had been 
previously isolated as a mixture of C-24 epimers. The structures of these three 
compounds were established by spectroscopic methods and chemical transformations and 
the molecular structures of (24/?)-24,25-epoxycycIoartan-3-one and (23/?)-3-oxolanosta- 
8,24-dien-23-ol were determined by single-crystal X-ray diffraction. In a 
radiorespirometric bioassay against M. tuberculosis, the epoxycycloartanes (24/?)-24,25- 
epoxycycloartan-3-one and (24/?)-24,25-epoxycycloartan-3p-ol exhibited minimum 
inhibitory concentrations of 8 pg/ml. In contrast, the lanostadiene-type triterpene (23/?)- 
3-oxolanosta-8,24-dien-23-ol showed no significant inhibition at 128 pg/ml, as did the
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acetate of (24/?)-24,25-epoxycycloartan-3(3-ol. Correlations of structural features and the 
MICs of the four triterpenes suggest that the presence of the C-3 keto and/or (3-hydroxy 
group, the cyclopropane ring and the epoxide moieties as in (24/? >-24.25- 
epoxycycloartan-3-one and (24/?)-24,25-epoxycycloartan-3|3-ol seem to play a major role 
in the in vitro antituberculosis activity. Both the cyclopropane and epoxide functions are 
absent in triterpene (23/?)-3-oxolanosta-8,24-dien-23-ol, resulting in its loss of activity 
(MIC 64-128 pg/ml). Also, the loss o f activity by introduction of a C-3 acetoxv group 
(MIC >128 pg/ml) strongly suggests that either a free hydroxyl or a keto group at C-3 in 
(24/?)-24,25-epoxycycloartan-3-one or (24/?)-24,25-epoxycycloartan-3(3-oI is required for 
significant activity. Cytotoxicity for Vero cells gave IC50 values of 71.8 pg/ml, 39.8 
pg/ml, and 103.6 pg/ml for triterpenes (24/?)-24,25-epoxycycloartan-3-one, (24/?)-24,25- 
epoxycycloartan-3(3-ol and (23/?)-3-oxolanosta-8,24-dien-23-ol, respectively.
In an attempt to study the structural dependence of antimycobacterial activity of 
the guaianolide dehydrocostus lactone and its derivatives, and to determine 
configurational and conformational effects on activity, m-chloroperoxybenzoic acid 
oxidations of dehydrocostus lactone were performed. Three new monoepoxides, one 
previously synthesized diepoxide, and two new diepoxides were obtained. Two o f the 
monoepoxides are C-10 epimers, while the 4(15)-monoepoxide has the 4 a -0 - 
configuration. The known 4(15),10(14)-diepoxide contains an C-10-a-epoxide and a 13- 
epoxide at C-4. Both new diepoxides contain a C-4 a-epoxy group and differ in the 
configuration of the epoxide ring at C-10. Allylic oxidation of dehydrocostus lactone 
with selenium dioxide//-butyl hydroperoxide afforded the known 3-epizaluzanin C. The 
relative configurations of the above compounds were established by one- and two­
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dimensional NMR techniques (‘H, i3C, COSY, NOESY, HMQC, and HMBC) as well as 
comparison with literature data. The molecular structures of 3-epizaluzanin C, the 
4P(15),10a(14)-diepoxide, and the 4a(15),10P(14)-diepoxide were determined by single­
crystal X-ray diffraction.
In radiorespirometric bioassays against Mycobacterium tuberculosis and M. 
avium, dehydrocostus lactone exhibited MICs of 2 and 16 pg/ml, respectively. In 
contrast, its monoepoxides and diepoxides as well as its hydrogenated derivatives and 
other analogues (3-epizaluzanin C, 7a-hydroxydehydrocostus lactone, micheliolide, and 
pumilin) showed significantly lower activities against M. tuberculosis. The above data 
allowed us to suggest that the antimycobacterial activity of the tested guaianolides is not 
as strongly determined by the exocyclic methylene lactone moiety, as by polarity factors. 
Activity is most dramatically reduced when at least one hydroxyl group is present in the 
molecule (3-epizaluzanin C, 7a-hydroxydehydrocostus lactone, micheliolide, and 
pumilin). The successive replacement of double bonds with epoxide groups also caused a 
significant loss of activity with the more polar diepoxides being less active than the 
monoepoxide analogues. As contrasted by the activity of the 4P(15),10a(14)-diepoxide 
and the 4a( 15), 10P( 14)-diepoxide, configurational and conformational influences seem 
to exist but appear to be of lesser importance. Since the most lipophilic guaianolide 
dehydrocostus lactone gives the highest antimycobacterial activity, it can be concluded 
that activity is most strongly influenced by the polarity of a given molecule. Therefore, 
within this structurally related group of sesquiterpene lactones, antimycobacterial activity 
is most likely controlled by the transport through the outer lipid layer o f mycobacteria.
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The root extracts of Inula helenium [Elecampane] (Asteraceae) and Rudbeckia 
subtomentosa [Sweet Coneflower] (Asteraceae) were chemically investigated for their 
active constituents. Chromatographic fractions of root extracts of I. helenium, which 
exhibited significant activities against M. tuberculosis, provided the known 
eudesmanolides alantolactone, isoalantolactone, and llaH , 13-dihydroisoalantolactone, 
which had been previously isolated from the roots of /. helenium. Active fractions from 
R. subtomentosa gave the known alloalantolactone and 3-oxoalloalantolactone. The 
structures of the above eudesmanolides were established by spectroscopic methods 
including ID and 2D NMR techniques as well as spectral comparison of previously 
reported data. Peracid epoxidation of alantolactone and isoalantolactone gave the 
derivatives a-epoxyalantolactone and a-epoxyisoalantolactone, respectively. Oxidation 
of alantolactone with OSO4 provided 11,13 dihydroxyalantolactone.
All natural and semisynthetic compounds were tested for biological activity 
against M  tuberculosis and demonstrated MICs ranging from 8 to >128 pg/ml. The 
sesquiterpene lactones alantolactone, isoalantolactone, 11a , 13-dihydroisoalantolactone, 
alloalantolactone, and 3-oxoalloalantolactone gave MICs of 32, 32, >128, 32, and 128 
pg/ml, respectively. Oxidative modifications by epoxidation of alantolactone produced 
5,6a-epoxyalantolactone, with a MIC of 8 jig/ml, a value significantly lower than 
observed for alantolactone with an MIC of 32 jig/ml. In contrast, 4,15a- 
epoxyisoalantolactone gave an MIC of 32 pg/ml. This value, which is the same as the 
starting isoalantolactone, leads us to suggests that the 4(15) double bond in 
isoalantolactone may be less important for biological activity, which could only be 
confirmed with further modifications. Oxidation of alantolactone to 11, 13-
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dihvdroxyalantolactone resulted in complete loss of biological activity with an MIC of 
>128 fig/ml. This strongly supports the necessity of the presence of the a, (3-unsaturated 
lactone group, which is quite likely acting as an alkylation moiety. Further support for 
the necessity of the a-methylene-y-lactone group is expressed in the high activity of 
isoalantolactone (32 pg/ml), when compared to the nonactive 1 l(l3)-dihydroderivative 
(>128 fig/ml).
Methanol extracts of the fruits of Meha volkensii provided two new and one 
known triterpenoids, which were shown to be triterpenes of the euphane (20R) series. 
The new 12(3-hydroxykulactone and 6P-hydroxykulactone were shown to be hydroxyl 
derivatives of kuiactone. The structures of 12P-hydroxykulactone and 6p- 
hydroxykulactone were elucidated by ID and 2D NMR (l3C, lH, 'H-'H COSY, HMQC, 
HMBC, and NOESY spectra) and FABMS studies. Also isolated was kulonate, which 
had been previously obtained from Melia azedarach together with kuiactone. All three 
compounds were evaluated for their inhibitory activity against M tuberculosis and were 
shown to have potent MICs ranging from 4 pg/ml to 16 fig/m 1. 12P-Hydroxykuiactone 
and kulonate showed MICs of 16 pg/ml, while 6P-hydroxykulactone had an MIC of 4 
pg/ml suggesting that the presence of a hydroxyl group at C-6 in 6P-hydroxykulactone 
significantly enhances biological activity.
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